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The VirB/D4 type IV secretion system (T4SS) of Agrobacterium tumefaciens functions 
to transfer substrates to infected plant cells through assembly of a translocation channel and a 
surface structure termed a T-pilus. This thesis is focused on identifying contributions of VirB10 
to substrate transfer and T-pilus formation through a mutational analysis. VirB10 is a bitopic 
protein with several domains, including a: (i) cytoplasmic N-terminus, (ii) single 
transmembrane (TM) α-helix, (iii) proline-rich region (PRR), and (iv) large C-terminal modified 
β-barrel. I introduced cysteine insertion and substitution mutations throughout the length of 
VirB10 in order to: (i) test a predicted transmembrane topology, (ii) identify residues/domains 
contributing to VirB10 stability, oligomerization, and function, and (iii) monitor structural 
changes accompanying energy activation or substrate translocation. These studies were aided 
by recent structural resolution of a periplasmic domain of a VirB10 homolog and a ‘core’ 
complex composed of homologs of VirB10 and two outer membrane associated subunits, 
VirB7 and VirB9. By use of the substituted cysteine accessibility method (SCAM), I confirmed 
the bitopic topology of VirB10. Through phenotypic studies of Ala-Cys insertion mutations, I 
identified “uncoupling” mutations in the TM and β-barrel domains that blocked T-pilus 
assembly but permitted substrate transfer. I showed that cysteine replacements in the C-
terminal periplasmic domain yielded a variety of phenotypes in relation to protein 
accumulation, oligomerization, substrate transfer, and T-pilus formation. By SCAM, I also 
gained further evidence that VirB10 adopts different structural states during machine 
biogenesis. Finally, I showed that VirB10 supports substrate transfer even when its TM domain 
is extensively mutagenized or substituted with heterologous TM domains. By contrast, specific 
residues most probably involved in oligomerization of the TM domain are required for 
biogenesis of the T-pilus. 
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Chapter 1. Introduction to Agrobacterium tumefaciens VirB/D4 Type IV Secretion 
System
 2 
Introduction 
Type 4 secretion systems (T4SS) are dynamic and multifunctional transport devices 
The translocation of macromolecules across the bacterial cell envelope is an important 
element in the establishment or progression of pathogenic relationships. Substrate 
translocation is achieved through specialized secretion systems. This thesis is centered on a 
group of ancestrally related translocation systems termed the Type IV Secretion Systems 
(T4SS) (1). These systems carry out a diverse array of functions and are classified into three 
subfamilies as: (i) conjugation machines, (ii) effector translocation systems, and (iii) DNA 
uptake and release systems (1). The VirB/VirD4 T4SS of Agrobacterium tumefaciens is a 
model system capable of transferring both DNA and protein substrates across the cell 
envelope and into the host cytoplasm. A. tumefaciens is a phytopathogen that uses the 
VirB/D4 T4SS to infect and genetically transform multiple species of plants (2). During the 
course of infection, the bacterium delivers a DNA-protein complex, called the transfer DNA or 
T-DNA, as well as protein substrates to plant cells with the outcome of infection resulting in the 
formation of plant tumors called Crown Galls (3). Although the overall infection process is 
highly complex and beyond the scope of this thesis, work described in this thesis sheds light 
into the mechanism of action of the VirB/VirD4 T4SS and phylogenetically related systems in 
mediating intercellular substrate transfer.   
 
The virulence (vir) genes encode the VirB/D4 T4SS subunits, named VirB1 through 
VirB11 and VirD4 (4). The VirB subunits can be separated into three categories according to 
known or predicted functions and subcellular locations at the cell envelope: (i) energetic 
subunits, (ii) channel subunits, (iii) T-pilus or other subunits (1) (Figure 1-1) (5). Three 
ATPases VirB4, VirB11, and VirD4, comprise the energetic subunits (1, 6). All three ATPases 
are associated with the inner membrane and required for substrate transfer (7-10), but only 
VirB4 and VirB11 are required for the formation of the T-pilus (6). The channel subunits 
include bitopic proteins VirB8 and VirB10, polytopic VirB6, and the outer membrane proteins 
VirB7 and VirB9 (10). The T-pilus subunits include VirB2 and VirB5 (1), in which VirB2 
assembles as the T-pilus and VirB5 is thought to localize at the T-pilus tip (11) (Figure 1-1). 
Although the VirB proteins are classified into different groups, they are all required to build a 
functional secretion channel and the extracellular T-pilus.  
 
As mentioned above, many T4SS can be loosely categorized based on ancestral 
lineage and function into three distinct areas, e.g. conjugation, protein translocation, and DNA 
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release/uptake (1). Across the bacteria and archaea, the different T4SS can vary widely in 
terms of their subunit compositions, but among the Gram-negative bacteria the T4SS 
invariably possess homologs of the VirB core subunits (VirB6 – VirB10), and at least two of the 
three ATPases (VirD4, VirB4) (12-14). In view of this conservation in sequence and probably 
also function, results of studies of individual T4SS subunits can have a broad importance. My 
studies of VirB10 have supplied new mechanistic information about the role of this subunit in 
machine assembly and function. In addition, the Waksman laboratory recently published 
results of ultrastructural studies of a T4SS encoded by the conjugative IncN plasmid pKM101 
from Escherichia coli (15, 16). These structural findings have led to predictions regarding 
VirB10 function and have therefore guided some of my experiments. The combination of 
structural and functional data presented in this thesis provides a better understanding of how 
T4SS assemble and function.  
 
An exciting development in the Christie laboratory was the determination of the T-DNA 
substrate route during channel translocation. This study utilized a formaldehyde (FA)-based 
crosslinking assay termed transfer DNA immunoprecipitation or TrIP (17). With TrIP, the 
translocation process was ordered spatially across the bacterial cell envelope though 
identification of FA-crosslinkable contacts between the translocating T-DNA substrate and VirB 
channel subunits. Specifically, the T-DNA substrate first forms a close contact at the 
cytoplasmic face of the channel with the VirD4 ATPase, also termed the substrate receptor or 
coupling protein, and then the VirB11 ATPase (17). Next, the T-DNA forms close contacts with 
the inner membrane channel subunits VirB6 and VirB8, and finally with VirB2 and VirB9 within 
the periplasm and possibly across the outer membrane. Of interest for the present studies, the 
T-DNA did not form close contacts with bitopic VirB10, although VirB10 was required for the T-
DNA transfer from the inner membrane VirB6/VirB9 to the periplasmic/outer membrane 
VirB2/VirB9 subunits (17). 
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Figure 1-1 Location of VirB/D4 T4SS subunits within the gram-negative cell wall  
Represented are the subcellular locations and topologies of the VirB (VirB1-VirB11) and VirD4 
subunits. Subunits are categorized based on reported or putative functions: energy, core 
complex, and other/T-pilus. Energetic subunits include the three ATPases VirD4, VirB4, and 
VirB11. The core channel components VirB6, VirB7, VirB8, VirB9, VirB10 are believed to form 
a transenvelope complex that acts as a scaffold for the secretion channel or the T-pilus. The 
T-pilus components include VirB2 and VirB5. The biogenesis of the T-pilus first includes 
maturation of VirB2 subunits at the inner membrane followed by polymerization of these 
subunits across the cell envelope to the cell exterior. IM, inner membrane, OM, outer 
membrane.   
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 6 
VirB10 is a multifunctional dynamic core subunit of the VirB/D4 T4SS 
This thesis focuses on defining the contributions of the bitopic subunit VirB10 to 
substrate transfer and T-pilus biogenesis. Based on sequence analysis, the VirB10 domain 
architecture is thought to consist of an N-terminal cytoplasmic domain, α-helix transmembrane 
(TM) domain, periplasmic proline-rich region (PRR), and a C-terminal periplasmic domain (12). 
An X-ray crystal structure is available for a portion of the VirB10 homolog, ComB10, from the 
Helicobacter pylori T4SS system (18). This structure shows that the C-terminal periplasmic 
domain of ComB10 adopts a modified β-barrel with two unusual α-helical extensions. An α1-
helix is positioned on the side of the β-barrel and extends perpendicular to the β-barrel 
strands. Another helical element, a helix-loop-helix (α2,α3), projects from the top of the β-
barrel. Part of the α2,α3 extension (termed the antennae projection or AP) was structurally 
unresolved, which could be an indicator of a flexible region. The β-barrel itself was unusual in 
the presence of a groove or depression on the β-barrel surface. In the crystal structure the β-
barrels of two monomers of ComB10 aligned in head-to-tail fashion and the β-barrel grooves 
formed the packing interface (18). This overall structure conveyed useful predictions for the 
VirB10 protein family.  
 
As noted above, VirB10 is required for both substrate transfer and T-pilus formation 
(19). Previously, the Christie laboratory presented evidence that VirB10 senses ATP utilization 
by the inner membrane ATPases VirD4 and VirB11 and, in turn, undergoes a conformational 
change (20). This conformational change is necessary for substrate transfer, and deduced 
from the findings that the translocating T-DNA failed to form close contacts with VirB2 and 
VirB9 in ATP-depleted wild-type cells or strains lacking VirB10 or the inner membrane 
ATPases (20). The energy induced conformational switch was identified as a change in 
protease susceptibility. These findings led to a working model that ATP hydrolysis combined 
with VirB10 energy sensing together act as a molecular switch to regulate substrate 
translocation through the distal portion of the translocation channel (20). 
Assembly of VirB7, VirB9, and VirB10 homologs as a ‘core’ complex 
Besides its role in energy sensing, recent structural data indicate that VirB10 
assembles with two other subunits, the VirB7 lipoprotein and VirB9, as a higher-order structure 
termed a ‘core’ complex. This core complex is believed to form part of the secretion channel 
that spans across the inner membrane, periplasm, and outer membrane. The argument for a 
core complex is supported by results of protein-protein interaction studies (21, 22) and further 
reinforced by the available structural information. The ultrastructural data were generated for a 
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‘core’ complex comprised of homologs of VirB7, VirB9, and VirB10 from the conjugation T4SS 
encoded by the E. coli plasmid pKM101. Initially, a structure obtained by cryoelectron 
microscopy (cryo-EM) showed that 14 copies each of the VirB7, VirB9, and VirB10 homologs 
(TraN, TraO, and TraF, respectively) assemble as a large, 1.05 megadalton (mDa), ring-
shaped complex (16). Further, the core channel complex is divided into two parts: (i) the O 
layer predicted to embed in the outer membrane, and (ii) I layer, believed to insert in the inner 
membrane. The O and I layer both have hollow chambers and thus the whole structure is 
cylindrical. The O layer is a complex of TraN, TraO, and TraF and creates a cap domain that 
possibly functions as the outer membrane pore (16). In contrast, the I layer appears to be 
largely composed of VirB10-like TraF. The dimensions of the core channel are such that the 
cap domain of the O layer resolved with a 10 Å diameter opening whereas the base of the 
channel made by the I layer resolved with a 55 Å diameter opening (16). These features 
therefore create a channel structure with a narrow opening at the cap or pore domain and 
large opening at the base of the channel. Due to the small diameter of the channel opening at 
the OM, it was proposed that the cap domain undergoes conformational changes in order to 
accommodate passage of large macromolecules such as DNA and protein substrates, or 
extrusion of the T-pilus (15, 16).  
 
Very recently, an X-ray-crystal structure of a portion of the pKM101 core complex was 
determined (15) (Figure 1-2). This structure corresponds to the O layer of the core complex. A 
surprising finding was that the OM channel and cap domain consists not of VirB9-like TraO, as 
had been previously predicted, but of the VirB10-like TraF. This pore is composed of 14 α-
helical projections from VirB10, specifically the α2,α3 helix-loop-helix or antennae projections 
(AP) (15) (Figure 1-2). These findings suggest that VirB10 is a scaffold for the core complex 
and also that the AP comprises the outer membrane pore. If this model is correct, VirB10 
would be the first described bacterial protein shown to span the entire Gram-negative bacterial 
cell envelope (23). As a result of these new structural developments, many questions have 
surfaced concerning the requirements for pore opening and closing. Overall, the combined 
structural and functional studies are providing valuable insights into how large macromolecular 
complexes assemble across the bacterial cell envelope. Our working model for T4SS machine 
morphogenesis posits that the VirB7, VirB9, and VirB10 subunits first assemble to form an 
intrinsically stable core complex. Next, the core complex recruits the other VirB subunits for 
further assembly of the secretion channel or, alternatively, the T-pilus.  
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In summary VirB10, a required subunit for T4SS-mediated substrate transfer and T-
pilus biogenesis possesses several novel and intriguing features. It is an ATP energy sensor, 
a structural scaffold for a large macromolecular machine, and a putative outer membrane 
pore.  
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Figure 1-2 T4SS outer membrane complex; outer membrane pore 
A. Ribbon diagram of the pKM101 X-ray crystal structure of the outer membrane complex 
(O layer).  
B. The structure tilted (Top view). The core complex is shown as light blue. The Tra 
subunit fragments are color-coded: TraF (VirB10) is green, TraO (VirB9) is red, TraN (VirB7) is 
black. The antennae projection (AP) of TraF (VirB10) is indicated with an arrow.  
 
This structure was resolved and published by (15). I used the coordinates from the published 
structure in the protein data bank (http://www.pdb.org) (accession code; 3JQO) along with the 
MacPyMOL visualization tool to create this figure. I have an educational (Academic) 
subscription to use MacPyMOL (PyMOL Molecular Graphics System, 2006, Delano scientific, 
LLC., http://www.pymol.org).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10 
 
 
 
 
 
 
 
 
 
 
 11 
Significance 
The ability of bacteria to transfer macromolecules to diverse cell types is an important 
adaptation of special importance for infection processes. This work seeks to extend previous 
studies concerned with understanding how T4SS are architecturally arranged and how they 
mediate substrate transfer across the bacterial cell envelope. Specifically, this thesis seeks to 
define the contributions of VirB10 to substrate transfer and T-pilus biogenesis through 
phenotypic characterization of mutations introduced into specific domains.   
 
In chapter 3, I collaborated with a technician (Vidhya Krishnamoorthy), graduate 
student (Jennifer E. Kerr), and postdoctoral fellow (Simon J. Jakubowski) (24). I present my 
specific contributions to this project. I used the substituted cysteine accessibility method or 
SCAM (25) to: (i) to determine VirB10 topology, (ii) refine our understanding of VirB10 
conformational dynamics, and (iii) explore VirB10 domain contributions to protein function. 
One interesting finding from this study is that a partial deletion of the α2,α3 antennae 
projection results in a block in T-pilus formation while maintaining substrate transfer. 
Moreover, the AP deletion mutation results in the release of VirB2 pilin into the milieu (24).  
 
In chapter 4, I focused on the VirB10 TM domain, seeking to define the underlying 
mechanism for my initial observation that Ala-Cys (i2) insertions in this domain selectively 
block T-pilus production without affecting substrate transfer. Mutations were introduced into 
two putative TM helix-helix interaction motifs and assayed for effects on oligomerization and 
protein function. I determined that a leucine-based motif– a possible Leu zipper - is important 
for T-pilus formation but not for substrate transfer. By TOXCAT, a bacterial reporter system 
designed to measure self-association of TM helices in membranes (26), I showed that VirB10 
weakly self-associates and that the capacities of VirB10 mutant TM domains to self-associate 
generally correlated with T-pilus production. 
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Bacterial strains and growth/induction conditions 
Agrobacterium tumefaciens A348 served as the wild-type strain for these studies (27). A348 
deleted of the virB operon and virB10 are strains PC1000 and PC1010, respectively (19, 28) 
(Table 2-1). Conditions for growth of A. tumefaciens cells and induction of vir genes have been 
previously described (29). Briefly, strains were taken from frozen glycerol stocks (-80°C) and 
streaked on MG/L plates (Luria Bertani (LB) plates supplemented with mannitol and 
glutamate) (30, 31). After 2-3 days growth at room temperature (~25°C; RT) fresh colonies 
from MG/L plates were inoculated into 5 ml MG/L broth media and grown overnight at RT on a 
shaker. To maintain plasmids in A. tumefaciens, appropriate antibiotics were added to the 
media at the following concentrations (in µg/ml): carbenicillin (100), tetracycline (5), kanamycin 
(100), gentamicin (100), spectinomycin (500) (24, 28). For induction of the virulence genes, 1 
ml of cells grown in MG/L to mid-exponential phase (OD600 of ~0.6-0.8) were harvested by 
centrifugation (3 min at 11,200 x g). Optical density readings were taken on a Beckman DU 
530 UV/VIS spectrophotometer. Harvested cells were re-suspended in 5 ml of vir induction 
media (ABIM; AB 5.5 minimal media containing 200 µl acetosyringone (100 mM) (32)). ABIM 
cultures were incubated while shaking at RT for 14-18 h and subsequently used for protein 
analysis.  
Construction of virB10 insertions, substitutions, and transmembrane domain swaps 
The oligo-directed mutagenesis method of Kunkel and McClary was utilized to generate codon 
insertions and substitutions in virB10 (33). In this method, a single stranded template is first 
created by transformation of the template plasmid into E. coli strain CJ236 (dut, ung) cells. 
These cells lack functional activity of dUTPase (dut) and uracil N-glycosylase (ung). Therefore, 
during plasmid replication uracils are incorporated as a substitute for thymines. The CJ236 
cells are infected with the E. coli bacteriophage M13K07, which packages plasmid strands as 
single-stranded DNA into viral particles. Uracil-containing single stranded DNA is purified from 
these viral particles through a series of phenol chloroform extractions and used for subsequent 
oligo-directed mutagenesis. Oligonucleotides containing mutations of interest are annealed to 
the single-stranded template; the annealed oligonucleotides then serve as primers for 
complementary strand synthesis with T4 DNA polymerase. The in vitro-synthesized double-
stranded plasmids are transformed into E. coli DH5α cells. In this background, the uracil-
containing strand is degraded while the mutant strand lacking uracils is replicated (33). In my 
experiments, pKVD10, encoding Plac-virB10, served as the template for construction of all 
residue insertions (Ala-Cys; GCA TGC), and residue replacements (cysteine; TGC, alanine; 
GCA, isoleucine; ATT). These Kunkel reactions utilized oligonucleotides with 12-15 base pair 
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sequence complementary to regions both upstream and downstream of the mutation. In 
addition, the mutations incorporated sequence changes that introduced an SphI or PstI 
restriction site, thus enabling diagnosis of the introduced mutations by restriction enzyme 
digestion (Table 2-2). Plasmids with mutations were identified by restriction enzyme analysis 
and verified through DNA sequencing (MMG core facility). Lastly, these ColE1 plasmids, which 
do not replicate in A. tumefaciens, were ligated to a broad-host-range (BHR) plasmid, pSW172 
(34) or pXZ151 (35), and the resulting cointegrate plasmids were introduced into A. 
tumefaciens cells by electroporation (36).  
 
Plasmids encoding VirB10 with heterologous TM sequences were created by PCR 
amplification of the N-terminus containing the respective TM sequence change (FtsN or pLA 
derivatives). PCR reactions utilized pKVD10 (carries Plac-virB10) as template and primers 
listed in Table 2-2. PCR products incorporated an N-terminal NdeI (CAT ATG) site and an 
SphI (GCA TGC) site inserted at the 50th codon position. The PCR products were digested 
with NdeI and SphI and the resulting fragments were introduced into similarly digested pIG50, 
a plasmid containing a phenotypically-silent SphI (GCA TGC) restriction site at codon position 
50 (24). Resulting plasmids encoded full-length VirB10 with the variant TM sequence. DNA 
constructs were verified through sequencing and then introduced into A. tumefaciens by 
ligation to a BHR plasmid and electroporation.  
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Table 2.1 Bacterial strains and plasmids 
 
Strains or 
plasmids 
Relevant Characteristics Source 
E.coli   
  DH5α          Genotype; λ- φ80d/lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rk-,mk+) supE44 thi-1 gyrA 
relA1 
Gibco-BRL / 
Invitrogen 
  CJ236 Genotype; dut ung thi relA; pCJ105(Camr) (37) 
  S17-1 Tra genes encoded by the broad-host-range plasmid 
RP4 incorporated in the chromosome for conjugal 
transfer of RSF1010 derivative (pML122Δkm) 
(38, 39)  
  MM39 malE; TOXCAT strain  (26) 
   
A. tumefaciens   
  A348  A. tumefaciens containing the octopine-type Tumor-
inducing (Ti) plasmid pTiA6NC 
(40) 
  A348Spcr Spcr: A348 recipient for conjugation (38) 
  PC1010 A348 pTiA6NC with a nonpolar ΔvirB10  (19) 
  PC1000 A348 pTiA6NC deleted of ΔvirB(1-11) operon (28) 
   
Plasmids   
pSW172 Tetr; broad-host-range IncP plasmid (34) 
pXZ151  Kanr; derivative of pSW172 encoding a Kanr cassette 
replacing Tetr 
(35) 
pML122ΔKm   Genr; mobilizable IncQ derivative (RSF1010) (41) 
pKVD10  
 
 
Crbr; pBSIISK+NdeI expressing Plac-virB10 ; parental 
plasmid for site-directed mutagenesis.  
(24) 
pIGXXa 
series        
 
Crbr; pKVD10 carrying in-frame Ala-Cys (GCA TGC) 
codon insertions at positions following the residue 
indicated.  
(24) 
pIG011-022a 
series  
 
Crbr; pKVD10 carrying single cysteine substitutions 
(TGC) in the PRR and β-barrel regions.  
 
(24) 
pIG043-049b 
series  
 
Crbr; pKVD10 carrying single cysteine substitutions 
(TGC) along the β-barrel antennae projection or AP  
This Study 
pIG024-025b 
series  
 
Crbr; pKVD10 carrying transmembrane Isoleucine 
replacements in the GA4 motif 
This Study 
pIG026-033b 
series  
 
Crbr; pKVD10 carrying single and triple 
transmembrane leucine to alanine replacements in 
atypical leucine zipper motifs 
This Study 
pIG034-036a,b Crbr; pKVD10 encoding various FtsN TM domain 
substitutions  
This Study 
pIG037-041b Crbr; pKVD10 encoding various poly-Leucine Alanine 
(pLA) TM domain substitutions  
This Study 
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pIG042b                   Crbr; pKVD10 carrying a replacement of conserved 
tryptophan 48 with alanine                                       
This Study 
pccKan Crbr, Kanr; TOXCAT cloning vector (26) 
pccGpA Crbr; TM domain of glycophorin A encoded in pccKan (26) 
pccGpA G83I Crbr; nondimerizing TM domain of glycophorin A 
encoded in pccKan 
(26) 
pccB10XX Crbr; TM domain sequences from native and mutant 
VirB10 encoded in pccKan 
This Study 
pCM50 Crbr; Encodes E1 FLAG-E2 from a ColE1 plasmid.  This Study 
pIG051 Crbr; Encodes N-terminal profinity-tagged virB10 This Study 
 
For expression in A. tumefaciens all listed ColE1 plasmids were ligated to either pSW172a or 
pXZ151b, and introduced into competent cells by electroporation.  
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Table 2.2 Oligonucleotides used for construction of VirB10 residue replacements, and 
transmembrane (TM) domain substitutions 
 
α-helical Antennae (AP) Cysteine Replacements  
M289C 5’-AACAGCACTCAAGAGGCATGC1TCCGCTAAAACG-3’ 
F298C 5’-GGTGCTAGCTGCCTGGCATGC1GCCTTGAACAGC-3’ 
S302C 5’-GCCAGCGTAGGTGCATGC1TGCCTGGAAGGCGCC-3’ 
N315C 5’-GTTATTTTGAAAGCTGCAG2AAGCTCATCCCGCC-3’ 
F317C 5’-TTGTTCACCGTTATTTTGGCAGCTG3TTGAAGCTCAT-3’ 
L329C 5’-GATGGTCGCCTTGCATGC1TGTCTCAGTTGTTTG-3’ 
T332C 5’-CGGTATGTTGATGCATGC1CTTAAGGGCTGTCTC-3’ 
Transmembrane (TM) Residue Substitutions 
G37I    5’-CGCGAGAACGACAATTCCGACGATAAGCTT4CTGAGACCC-3’ 
A41I   5’-TAGCCATATG5AGGCTTAACGATAAAATGAGAACGACACC-3’ 
L33A  5’-ACCTCCGACGATCGCTTTCTGGGATCC6CGAAAGACGCCG-3’ 
V35A  5’-GAACGACACCTCCGGCGATAAGCTT4CTGAGACCC-3’ 
L40A 5’-CTAGCCATATG5AGGCTTAACGATAACGCGGCAACGACACC-3’ 
L42A 5’-CCAAATGAGGCTTAAGCTAGC7CGCGAGAACGACACC-3’ 
I47A 5’-CACCTTCTTTTGGCGGCCGC8CTAGCCAAGCGAGGCTTAAC-3’ 
L49A 5’-CACCTTCTTTTGGCGGCCGC8CTGCCCAAATGAGGCT-3’ 
L33A, L40A, 
I47A 
5’-CCCACCTAGCCAAGCGAGGCTTAACGATAACGCGGCAACG 
ACACCTCCGACGATCGCTTTCTGGGATCC6CGAAAGACG-3’ 
V35A, L42A, 
L49A 
5’-GACGCCCACCTGCCCAAATGAGGCTTAAGCTAGC7CGCG 
AGAACGACACCTCCGGCGATCAATTTCTG-3’ 
TOXCAT PCR Primers 
FP-TM33 5’-GGGTCTCAGAAATCTAGA9TTGATCGTCGGAGGT-3’ 
RP-TM50 5’-CTTTTGACGCCCGGATCC6CTAGCCAAATGAG-3’ 
FP-TM33-(L33A) 5’-GGGTCTCAGAAATCTAGA9GCGATCGTCGGAGGT-3’ 
FP-TM33-(V35A) 5’-GGGTCTCAGAAATCTAGA9TTGATCGCCGGAGGT-3’ 
RP-TM50-(I47A) 5’-CTTTTGACGCCCGGATCC6CTAGCCAAGCGAG-3’ 
RP-TM50-(L49A) 5’-CTTTTGACGCCCGGATCC6CTGCCCAAATGAG-3’ 
FP-TM33-(35AC) 5’-CGTCTTTCGGGGTCTCAGAAATCTAGA9TTGATCGTC-3’ 
Transmembrane (TM) domain substitutions 
B10-Nterminal-S 5’-CATATG5AATAACGATAGTCAGCAAGCGGC-3’ 
B10PtN-Termi-
NdeI 
5’-AATTTCACACAGGAAACACATATG5AATAACGATAGTCAG-3’ 
FtsN(35-50) 5’-GCATGC1AATGAAGTACAGACCACCGATAAAGGTCACAA 
GAACGGCGGCAGCGACGATAAGCTTCTGAGACCCCGAAAG-3’ 
FtsN-L47A 5’-CACCTTCTTTTGACGCCCGCATGC1AATGAAGTATGCAC 
CACCGATAAAGGTCACAAGAAC-3’ 
FtsN-
L33A,L40A,L47A 
5’-CACCTTCTTTTGACGCCCGCATGC1AATGAAGTATGCACCAC 
CGATAAAGGTCACTGCAACGGCGGCAGCGACGATAGCCTT 
CTGAGACCC-3’ 
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pLA (33-50, W48) 5’-GCATGC1CGCCAGCCACAGCGCCAGCGCCAGCGCCAGCGC 
CAGCGCCAGCGCCAGCGCCAGTTTCTGAGACCCCGAAAGACG 
CCG-3’ 
pLA (33-50) 5’-GCATGC1CGCCAGCGCCAGCGCCAGCGCCAGCGCCAGCG 
CCAGCGCCAGCGCCAGCGCCAATTTCTGAGACCCCGAAAGAC 
GCCG-3’ 
pLA (27-50) 5’-GCATGC1CGCCAGCGCCAGCGCCAGCGCCAGCGCCAGC 
GCCAGCGCCAGCGCCAGCGCCAGCGCCAGCGCCAGCGCAA 
GACGCCGGCGATGTTTGTCGGAGACCAGGGATCC-3’ 
W48A 5’-CTTCTTTTGTCGAC10CACCTAGCGCAATGAGGCTTAAC-3’ 
pLA (33-50, W48, 
VL/SL) 
5’-CTTCTTTTGACGCCCGCATGC1CGCCAGCCACAGCGCCA 
GTAACGACGCCAGGAGAACCGCCAGCGCCAGCGCCAATTTCT
GAGACCCCGAAAGACGCCG-3’ 
pLA (33-50, W48, 
L40) 
5’-CTTCTTTTGACGCCCGCATGC1CGCCAGCCACAGCGCCAGC 
GCCAGCGCCAGCAGCAGCGCCAGCGCCAGCGCCAATTTCTGA 
GACCCCGAAAGACGCCG-3’ 
 
Bases in bold identify silent restriction sites: 1SphI (GCATGC), 2PstI (CTGCAG), 3PvuII 
(CAGCTG), 4HindIII (AAGCTT), 5NdeI (CATATG), 6BamHI (GGATCC), 7NheI (GCTAGC), 
8NotI (GCGGCCGC), 9XbaI (TCTAGA),10SalI (GTCGAC). 
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Protein analysis by western blotting 
To assay for accumulation of VirB subunits, vir- induced cells were harvested, cell numbers 
were normalized by adjusting to equivalent optical densities (OD600), and cells were re-
suspended in Laemmli’s buffer (50 mM Tris-HCl, 4% SDS, 20% glycerol, 20 mM dithiothreitol 
(DTT), 1% β-mercaptoethanol (β-ME), 0.1% bromophenol blue, pH 6.8) and boiled for 10 min. 
When assaying for possible Cys-mediated intermolecular crosslinks, cells were suspended in 
Laemmli’s buffer lacking reducing agents β-mercaptoethanol and dithiothreitol. The boiled cell 
extracts were resolved by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis 
(SDS-PAGE) or a tricine-SDS-PAGE as previously described (19). Separated proteins were 
then transferred to nitrocellulose membranes and incubated overnight with anti-VirB antibodies 
and then for 3 h with goat anti-rabbit antibodies conjugated to alkaline phosphatase (AP) or 
horseradish peroxidase (HRP) (New England Biolabs) for immunodetection. For TOXCAT, the 
steady state levels of the ToxR-B10TM-MBP proteins were assessed using an anti-MBP 
monoclonal antibody conjugated to horseradish peroxidase (HRP). AP activity was detected 
by the addition of the chemical reagents 5-Bromo-4-Chloro-3-Indolyl (BCIP) and 
Nitrotetrazolium blue chloride (NBT). Detection of HRP was done using an enhanced 
chemiluminescence (ECL) kit (Thermo Scientific) and blue lite autoradiography film 
(ISCBioExpress, Kaysville, UT).  
T-pilus isolation (shear assay)  
T-pili were isolated by mechanical shearing and ultracentrifugation as previously described 
(24, 38). Briefly, a 500 µl aliquot of vir-induced A. tumefaciens cells prepared as described 
above were spread on ABIM agar plates, followed by incubation for 3-5 days at 18°C. Cells 
were gently scraped from ABIM plates and collected in 1 ml KPO4 buffer (50mM, pH 5.5). To 
recover T-pili from the cell surfaces, the cell suspension was repeatedly passed though a 25-
gauge needle. Sheared cells were separated from T-pili by centrifugation at 14,000 x g for 30 
min at 4°C, followed by filtration of the supernatant through a cellulose acetate membrane 
(0.22-µm-pore-size; VWR sterile syringe filter). T-pili were then pelleted by ultracentrifugation 
at 100,000 x g for 1 h at 4°C. The pellet was re-suspended in Laemmli’s buffer and 
electrophoresed through a tricine-SDS-polyacrylamide gel. The presence of pilin, monitored by 
western transfer of proteins to nitrocellulose and immunostaining with anti-VirB2 antibodies, 
served as a diagnostic for T-pilus production (38, 42).  
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VirB2 pilin surface assay 
T-pilus production was also monitored with a surface colony blot assay (24). One milliliter 
cultures of vir-induced cells with equivalent optical densities (OD600), were pelleted by 
centrifugation and cells were re-suspended in 100 µl of ABIM liquid media. This suspension 
was then spotted in 25 µl aliquots on an ABIM agar plate and incubated at 18°C for 3 days. 
Cells were then transferred to a nitrocellulose membrane and the resulting membrane was 
subjected to immunostaining with anti-VirB2 antibodies for detection of surface-exposed pilin. 
Virulence assays 
The capacities of A. tumefaciens strains to transfer DNA and protein substrates through the 
VirB/VirD4 T4SS were assessed with a plant tumor formation assay (19, 43). Briefly, glycerol 
stocks were streaked on MG/L agar plates and strains were grown for 2-3 days at RT. These 
fresh cells were inoculated onto wounded leaves of the succulent plant, Kalanchoe 
daigremontiana. Wounding was accomplished by scratching the leaf with a sterile wooden 
applicator. Each leaf was co-inoculated with A348 (wild-type; positive control) and ΔvirB10 
(avirulent mutant strain; negative control), and virulence of a given strain was affirmed by 
inoculation of at least 3 different leaves. Inoculated leaves were observed for tumor formation 
over a 4-6 week period.  
Conjugation assays  
The capacities of A. tumefaciens strains to transfer DNA through the VirB/VirD4 T4SS were 
also tested with an interbacterial conjugation assay (24, 41). First, the mobilizable IncQ 
plasmid pML122ΔKm (an RSF1010 derivative) was introduced into A. tumefaciens strains of 
interest by conjugative transfer using E. coil S17-1 (pML122ΔKm) as a donor strain. E. coli 
S17-1 efficiently delivers IncQ plasmids to A. tumefaciens cells due to the presence of the 
plasmid RP4 (IncP) transfer region in its chromosome (38, 39). Next, A. tumefaciens strains 
carrying pML122ΔKm served as donors in mating experiments with a Spcr A348 derivative 
(24, 41). Briefly, A. tumefaciens donor and recipient cells were induced for expression of the 
vir genes for 6-8 h by shaking at RT. Cells were harvested and mixed in a 1: 5 ratio of donors 
to recipients. Five microliters of these mixtures were spotted on sterile nitrocellulose filters 
placed on top of an ABIM agar plate and incubated for 4-5 days at 18°C. The mating mixtures 
were re-suspended in MG/L media, serially diluted, and plated on antibiotic-containing media 
to select for transconjugants and donors. Transfer frequencies were reported as the number of 
transconjugants per donor cell. For each strain, mating experiments were carried out in 
triplicate and results of a representative experiment are reported. 
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MPB labeling  
MPB labeling of Cys-substituted VirB10 mutants were carried out as previously described (24). 
Briefly, A. tumefaciens strains grown in MG/L were used to inoculate 25 ml ABIM media in 125 
ml flasks. These flasks were incubated in a RT shaker (~ 200 rpm) for 14-18 h to an optical 
density (OD600) of  ~0.5. Cells were pelleted and re-suspended at an OD600 of 12 in 500 µl of 
buffer A (100 mM HEPES, 250 mM sucrose, 25 mM MgCl2, 0.1 mM KCl, pH 7.5) with or 
without the thiol blocking reagent 4-acetamido-40-maleimidylstilbene-2, 20-disulphonic acid 
(AMS; Molecular Probes) at a final concentration of 5 mM. AMS-exposed cells were incubated 
at RT for 30 min, and then AMS was removed by pelleting the cells with centrifugation and 
aspirating the AMS containing buffer A. These cells were washed with 10 ml of fresh buffer A. 
AMS-pretreated and untreated cells were exposed to 3-(N-maleimidylpropionyl) biocytin (MPB; 
Molecular Probes). MPB and cells were gently mixed in a final concentration of 100 µM MPB 
and incubated at RT for 5 min. To quench the reaction, cells were washed with buffer A 
containing 20 mM β-mercaptoethanol. To determine accessibility of cysteine residues 
introduced in the putative cytoplasmic and transmembrane regions, cells were lysed by 
sonication prior to MPB labeling. 
Isolation and detection of MPB-labeled VirB10 
MPB labeled cells were re-suspended in 200 µl of TES (10 mM Tris, 5 mM EDTA, 2% SDS, 
pH 7.5) and vortexed for 30 min at 37°C. Next 250 µl of buffer C (150 mM Tris, 0.5 M sucrose, 
10 mM EDTA, pH 8.0) was added. These samples were then incubated with lysozyme at a 
final concentration of 1 mg ml -1 on ice for 1 h. The samples were vortexed for 15 min at 37°C. 
To each of these samples, 20 µl of Triton X-100 were added, as well as 30 µl of an EDTA-free 
protease inhibitor cocktail (Pierce Biochemicals) and 13 µl from a 1 M MgCl2 stock solution. 
These samples were then vortexed for 10 min at 25°C, followed by incubation for 3 h at 4°C 
with gentle rocking. The detergent-solubilized cell extracts were diluted with 900 µl of buffer C, 
and clarified by centrifugation at 14,000 x g for 15 min. The supernatant was incubated with 
protein A-sepharose CL4B beads (Pharmacia) (30 µl bed volume) for 60 min at RT. The 
supernatant and protein A-sepharose with non-specifically bound proteins were separated by 
centrifugation for 5 min at 5,000 x g. The supernatant was incubated with protein A-sepharose 
beads previously coupled to anti-VirB10 antibodies, and then the mixture was incubated with 
gentle rocking overnight at 4°C. The beads were washed twice in 1% Triton X-100 solution for 
10 min, and once in a 0.1% Triton X-100 solution. To these beads, Laemmli’s buffer was 
added and samples were analyzed by western blotting as previously described (24).  
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TOXCAT experimental procedures 
For the TOXCAT experiments, constructs expressing ToxR-B10TM-MBP were made as 
follows. The Escherichia coli malE strain MM39 and vectors, pccKan, pccGpA-WT, and 
pccGpA-G83I were obtained from Dr. Donald Engelman (Yale, New Haven, CT). Plasmids 
encoding the native TM sequence as well as TM sequences with mutations served as 
templates for PCR reactions to amplify the TM sequence of interest with the addition of 5’ and 
3’ flanking XbaI and BamHI sites, respectively. Next, PCR products and pccKan were similarly 
digested, ligated, and the products pccB10XX were constructed (Table 2.1 and Table 2.2). 
Native and mutant TM sequences in the TOXCAT vector were confirmed by DNA sequencing.  
 
The pccB10 and derivative plasmids were introduced into MM39 cells and tested for protein 
synthesis, and ability to complement maltose metabolism to confirm correct orientation of the 
bitopic protein at the inner membrane. To quantify TM-mediated dimerization of ToxR, cell 
lysates were assayed for chloramphenicol acetyltransferase (CAT) activity (44). Briefly, to test 
for maltose utilization of MM39 cells expressing ToxR-B10TM-MBP, cells were grown overnight 
in 0.4% glucose M9 minimal broth media while shaking. The cells were harvested, washed, 
and streaked on a 0.4% maltose M9 minimal media plate. These plates were incubated for 2 
days at 37°C after which strains were monitored for growth. Cells expressing MBP in the 
periplasm (pMal –p2) and cytoplasm (pMal –c2) (New England Biolabs) were also included as 
positive and negative controls, respectively (26).  
 
To quantify chloramphenicol acetyltransferase (CAT) activity, cells expressing ToxR-B10TM-
MBP were first grown overnight in a 37°C shaking incubator in LB broth media containing 100 
µg/ml of carbenicillin. This culture was used to inoculate a fresh 5 ml LB culture, which was 
then incubated at 37°C to an OD420 of ~1.0. Cells numbers were normalized to the same 
OD420 value, harvested, washed, and re-suspended in 2 ml sonication buffer (25 mM Tris, 2 
mM EDTA, pH 8.0). Cells were sonicated on ice for 4 min (Branson 250 Analog sonicator, 
output= 2, duty cycle= 50%). A sample of the whole cell lysate was saved and used for 
western blot analysis. The remainder was centrifuged at 13,000 x g for 20 min and the 
supernatant was saved on ice for CAT assays. For detection of CAT activity, an enzymatic 
reaction was traced for absorbance at 412 nm for 5 min in a reaction mixture consisting of 10 
µl cell lysate, 10 µl of 2.5 mM chloramphenicol, and 250 µl of reaction buffer (100 µM acetyl-
CoA, 0.4 mg/ml of DNTB or 5,5’-dithiobis(2-nitrobenzoic acid), 100 µM Tris-HCl, pH 7.8) (44). 
A blank reaction mix, lacking chloramphenicol, was traced to determine the background 
absorbance. The kinetic trace data with chloramphenicol was revised to account for 
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background absorbance and was subsequently used to calculate the CAT enzyme activity. 
Reported CAT activities are mean values from three separate experiments and all kinetic 
traces were performed on a Beckman DU 530 UV/VIS spectrophotometer.  
Construction of profinity-VirB10 
The profinity tag was PCR amplified from the pPal expression vector (Bio-Rad; obtained from 
Dr. Kevin Ridge, Biochemistry Dept., UT Houston Medical School) with the addition of 5’ and 
3’ flanking NcoI and NdeI-linker-BamHI sites, respectively. This PCR product and 
pBluescriptIIKS (pBSIIKS-NcoI) were both digested with NcoI and BamHI and ligated together. 
The resultant plasmid, pBSIIKS-profinity, was digested with NdeI and SacI and the virB10 
gene flanked by NdeI and SacI sites was inserted, generating the profinity-tagged virB10 gene 
fusion. This plasmid was verified through automated DNA sequencing and later introduced into 
A. tumefaciens for phenotypic and biochemical studies.  
Outer membrane channel gating assay through detection of substrate (FLAG-VirE2) 
release 
To assay for outer membrane channel gating defects, I tested for release of T4SS substrates 
(FLAG-VirE2) to the cell surface by use of an assay developed by Dr. L. Banta at Williams 
College. All A. tumefaciens strains used in these studies produced native or mutant forms of 
VirB10 as well as FLAG-VirE2. VirB10 carrying a G272R mutation served as a positive control 
for leaking of FLAG-VirE2, as this has been shown to confer leakage of the VirB/VirD4 channel 
(L. Banta, personal communication). Briefly this assay is identical to the colony blot assay 
described above for the detection of T-pilus; however, here the anti-FLAG monoclonal or anti-
VirE2 polyclonal antibodies were used for immunodetection.  
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Chapter 3. Cysteine-based Mutagenesis of VirB10: Applications for Topology 
Modeling, Studies of Conformational Dynamics, and Assignments of Domain 
Functions 
 
 
 
 
 
 
 
 
 
 
Note: Data presented in this section were used in a published manuscript: “Agrobacterium 
VirB10 domain requirements for type IV secretion and T pilus biogenesis.” Molecular 
Microbiology (2009) 71(3), 779-794. This study was done in close collaboration with other 
laboratory members, Simon J. Jakubowski, Jennifer E. Kerr, and Vidhya Krishnamoorthy. 
Here, I present my contributions to the finished manuscript. Permission was given to 
reproduce and/or modify content for the purpose of this thesis. I have a license agreement 
(license number; 2501481389405) with the publisher John Wiley and Sons provided by the 
Copyright Clearance Center (CCC).  
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Introduction 
The A. tumefaciens VirB/D4 T4SS consists of a channel that conveys DNA and protein 
substrates to infected plant cells and a filamentous surface structure termed the T-pilus that 
functions to initiate contacts between the bacterium and host target cells (45-47). Recent 
studies suggest that VirB10-like proteins contribute in at least three important ways to the 
assembly and function of cognate T4SS’s. First, VirB10 is a component of a ‘core’ complex 
that spans the entire cell envelope and is required for stabilization of other VirB subunits 
during machine biogenesis. Current structural models depict VirB10 as a scaffold subunit of 
the core complex. These models are based on an X-ray crystal structure of the Helicobacter 
pylori ComB10 (18), a cryoelectron microscopy (Cryo-EM) structure of the pKM101 core 
complex composed of homologs of VirB7, VirB9, and VirB10 (16), and an X-ray structure of a 
portion of the pKM101 core complex (15).   
 
Second, VirB10 undergoes a conformational switch upon sensing of ATP energy 
consumption by the inner membrane associated ATPases VirB11 and VirD4 (20). These 
ATPases, plus the VirB4 ATPase, are thought to supply power through conversion of chemical 
energy derived from ATP hydrolysis to a mechanical force to promote machine assembly 
and/or substrate transfer through the T4SS apparatus (4, 20). The conformational switch in 
VirB10 was detected as a change in protease susceptibility between wild-type cells and ATP-
depleted cells or strains lacking VirB11 or VirD4 (20). The conformational switch was required 
for stable interaction of VirB10 with the outer membrane subunits VirB9 and VirB7 and for T-
DNA translocation through the distal portion of the translocation channel as shown by a 
substrate-trapping assay (17, 20). VirB10 interacts with all three ATPases either directly or 
indirectly, as shown by co-immunoprecipitation (48) or affinity chromatography with a 
functional glutathione-S-transferase (GST) tagged derivative of VirB10 (S. J. Jakubowski, 
unpublished data).  
 
Finally, the structural data suggest that an α-helical domain of VirB10 termed the 
antennae projection (AP) forms a pore at the outer membrane. This is a surprising finding 
given that such a pore is composed of alpha helices. In all but one other documented case, 
the E. coli Wza protein, outer membrane proteins insert as β-barrels, not as α-helices (49). 
The presumptive VirB10 AP pore is proposed to be the conduit for passage of T4SS 
substrates and possibly also the T-pilus across the outer membrane. However, this model 
remains to be rigorously tested. 
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At the outset of this study, we proposed that VirB10 forms a number of intersubunit 
contacts along its length that are required for core complex assembly, sensing of ATP energy 
use by the inner membrane ATPases, and substrate transfer. Prior studies supplied evidence 
for homomeric and heteromeric interactions (20, 21, 30, 48, 50). As noted above, VirB10 
extensively interacts with VirB9 and VirB7 to form the core complex. Additionally, there is 
evidence from the Christie laboratory and other laboratories that VirB10 interacts directly with 
the VirD4 ATPase, and indirectly or directly with the VirB4 and VirB11 ATPases (48). VirB10 
was also shown to interact in a two-hybrid screen with bitopic VirB8 and likely also interacts 
with the polytopic subunit VirB6 (21, 51). The contacts identified in the pKM101 core complex 
X-ray structure guide our predictions for VirB7, VirB9, and VirB10 interactions; however, the 
nature of other VirB10 heteromeric interactions and the importance of these interactions for 
machine function are not known.  
 
To explore the role of distinct domains of VirB10 to binding partner interactions and 
protein function, I initiated a structure-function study based in part on the ComB10 and TraF X-
ray crystal structures. Phenotypic studies of 2-residue insertion mutations as well as Cys 
substitution mutations confirmed a predicted bitopic topology for VirB10, identified discrete 
contributions of the transmembrane (TM) domain and AP to substrate transfer and T-pilus 
biogenesis, and supplied further evidence for structural flexibility of the VirB10 AP. A 
concluding section of this chapter focused on the AP domain through phenotypic analyses of 
cysteine substitution mutations. I examined whether these mutant alleles complement a virB10 
gene deletion and whether the engineered cysteine residues are surface displayed as 
predicted for a loop domain of the AP (15). 
Results 
Ala-Cys insertion mutations in the putative TM domain do not affect substrate transfer 
but block T-pilus formation 
VirB10 homologs in several conjugative systems have been reported to interact with 
cognate VirD4-like ATPases (52, 53). In the Christie laboratory, a former postdoctoral fellow, 
K. Atmakuri supplied evidence that VirD4 and VirB10 form immunoprecipitable complexes in 
detergent solubilized cell extracts (48). VirB10 also has a unique ability to sense ATP energy 
use by the VirD4 or VirB11 ATPases that ultimately triggers a conformational change of 
probable importance for protein function. In view of these findings, I sought to explore the 
possibility that the N-terminal cytoplasmic and α-helical TM domain could be responsible for 
mediating interaction with VirD4 and energy sensing. To test this hypothesis, I created ten Ala-
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Cys insertion mutations at five residue intervals along the N-terminus (Figure 3-1). The goal 
was to determine whether these insertion mutations would disrupt VirB10 function and, if so, 
attempt to identify an underlying mechanism by assaying for formation of VirB10 – VirD4 
complexes by co-immunoprecipitation. Full phenotypic characterization of all Ala-Cys mutant 
proteins is described in Jakubowski et. al. (24). Here, I will present my contributions to this 
larger study.   
 
I found that nearly all 10 of the i2 mutant proteins accumulated at abundant levels. The 
one exception, a mutant with an i2 mutation at residue 35 within the presumptive TM domain 
was less abundant than the other mutants, suggestive of a perturbing effect on protein stability 
(Figure 3-2). In addition, all of the i2 derivatives supported DNA transfer as shown by the 
capacity of the corresponding mutant strains to incite tumor formation on plant leaves (Figure 
3-2). The functionality of the VirB10.i2 mutant proteins with respect to T-DNA transfer 
supported the notion that the mutants retained the capacity to interact with and sense ATP 
energy use by the inner membrane ATPases. Another lab member, V. Krishnamoorthy,  
assayed for VirB10.i2 complex formation with the VirD4 ATPase by co-immunoprecipitation. 
She found that all of the mutant proteins co-precipitated with VirD4, whereas a mutant deleted 
of the first 46 residues of VirB10 (spanning the cytoplasmic and TM domains) did not form a 
complex with VirD4 (24). Together, the functionality of the VirB10.i2 mutant proteins and their 
capacity to interact – directly or indirectly – with VirD4 suggests the mutant proteins support 
machine biogenesis and retain the capacity to sense ATP energy use by the inner membrane 
ATPases.   
 
Interestingly, when another graduate student, J. Kerr, assayed for the capacity of 
strains producing the VirB10.i2 mutant proteins to elaborate T-pili, three strains made little or 
no detectable T-pilus. Strains with insertions at residues 35 and 45 of VirB10 elaborated low 
levels of T-pilus and a strain with an insertion at residue 40 elaborated no detectable T-pilus 
(24). Therefore, derivatives with i2 mutations in the presumptive TM domain supported 
substrate transfer but blocked T-pilus formation. Note that a deletion of the TM domain renders 
cells transfer-minus (Tra-). Therefore, although the TM domain is essential for VirB10 function, 
i2 mutations that would be predicted to shift the register of the transmembrane α-helix 
selectively disrupt T-pilus biogenesis. These initial findings formed the basis for further studies 
described in Chapter 4 to decipher the contribution of the TM domain to T-pilus production. 
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 Figure 3-1 VirB10 domain organization and mutation positions 
Domain diagram of VirB10 indicating locations of all Ala-Cys (i2) insertions and cysteine 
substitution mutations.  
 
Schematic of VirB10 was taken from (24). This figure was modified to include Cys residue 
replacements located in the antennae projection (AP) in the β-barrel domain. I have a license 
agreement between the publisher, John Wiley and Sons, to include this content in my thesis 
(license number; 2501481389405). I isolated and introduced all mutations into A.tumefaciens 
except those indicated with an asterisk (*); these were constructed by Ms. V. Krishnamoorthy.  
 
Black dots represent sites of i2 mutations. Cyto, cytoplasm; TM, transmembrane domain; 
PRR, proline rich region; α1, α-helical extension or level arm from the β-barrel domain, α2-α3 
(AP) helix-loop-helix extension or antennae projection (AP) from the β-barrel domain.  
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Figure 3-2 Effects of Ala-Cys insertion mutations on protein function 
Western blot analysis of total cell extracts for all 10 Ala-Cys insertions introduced along the 
cytoplasmic and transmembrane domains of VirB10. Equivalent optical densities of induced 
cells were used for protein analysis by western blotting. Cells re-suspended in Laemmli’s 
buffer, boiled for 10 min, and loaded on 12.5% SDS-polyacrylamide gels. Relative levels of 
VirB10 derivatives were visualized by western blotting and immunostaining with anti-VirB10 
antibodies.  
 
Strains: A348, WT A. tumefaciens; ΔB10, PC1010; Ala-Cys mutations synthesized in a 
PC1010 strain background.  
 
Ability to transfer DNA substrates was determined through plant virulence assays. K. 
daigremontiana plant leaves were co-inoculated with A348, ΔB10, and the VirB10 Cys 
mutants, and monitored after 4-5 weeks for the presence (+) or absence of tumors (-). A348 
(WT) and ΔB10 served as positive and negative controls, respectively. Virulence assays were 
repeated 3 times.  
 
These data were taken and modified from (24). I have a license agreement between the 
publisher, John Wiley and Sons, to include this content in my thesis (license number; 
2501481389405). 
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Confirmation of a VirB10 bitopic topology by SCAMTM 
I next utilized the substituted cysteine accessibility method (SCAMTM) to test the 
prediction that VirB10 stably integrates as a bitopic protein into the inner membrane (25). In 
SCAM, natural or engineered cysteine residues are assayed for accessibility to a membrane-
impermeable, thiol-specific reagent, in this case 3-maleimidylproprionyl biocytin (MPB, 
Molecular Probes). MPB is a maleimide derivative linked to biotin and due to its molecular size 
(~500 daltons, Da) readily diffuses through outer membrane pores. MPB only inefficiently 
crosses the inner membrane under the experimental conditions used in our studies (25). MPB 
labeling of Cys residues that do not disrupt protein function thus are indicative of a periplasmic 
or more distal location, whereas MPB inaccessibility is suggestive of cytoplasmic or inner 
membrane localization. This is an attractive method to determine residue disposition relative to 
the inner membrane. MPB labeling also can be used to assess whether a protein associates 
dynamically with the inner membrane in different genetic contexts or experimental conditions. 
This question is relevant for VirB10, because a ‘shuttling’ mechanism from the inner to outer 
membrane has been proposed for another energy transducer, TonB, on the basis of MPB 
labeling of Cys residues in an N-terminal cytoplasmic domain of this bitopic protein (54).  
 
In my study, none of the N-terminal Cys insertions deriving from the Ala-Cys insertions 
was MPB labeled in whole cells, consistent with a cytoplasmic and transmembrane localization 
(Figure 3-3). By contrast, Cys substitutions positioned more C-terminally were efficiently 
labeled, consistent with the predicted locations of the PRR, α1 helix, and β-barrel domains in 
the periplasm. Sonication of cells prior to MPB labeling renders cytoplasmic Cys residues 
accessible to MPB and here resulted in strong labeling of Cys residues inserted at positions 5, 
10, 15, and 20 relative to the N-terminus of the protein. Residue 25 labeled weakly, whereas 
residues 30, 35, 40, 45 and 50 did not label. For all residues in which MPB labeling was 
detected in whole cells, pretreatment with a nonbiotinylated maleimide derivative (AMS) 
effectively blocked subsequent MPB labeling. Together, these results support a topology 
model in which residues 1 to 25 are cytoplasmic, residues 30 to 50 insert in the inner 
membrane, and more C-terminal domains are periplasmic. These results also indicate that 
VirB10 does not dissociate from the inner membrane and shuttle to the outer membrane upon 
energy activation. 
 
 
 
 33 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3 Results of MPB labeling accessibility  
Top panel: MPB labeling of whole cells and bottom panel is labeling of lysates. Strains 
synthesizing C-terminal cysteine mutant proteins were labeled in the presence (+) and 
absence (-) of a blocking reagent AMS. Labeled proteins were resolved on a 12.5% 
polyacrylamide gel, and blots were incubated with avidin-HRP and developed with commercial 
enhanced chemiluminescence (ECL) reagents. Strains: ΔB10, PC1010; B10, PC1010 
(pKVD10) expressing wild-type VirB10; PC1010 (pIGXX) expressing mutant alleles shown. 
 
VirB10 mutations with an asterisk (*) were constructed and introduced into A. tumefaciens by 
V. Krishnamoorthy. 
 
These data were taken and modified from (24). I have a license agreement between the 
publisher, John Wiley and Sons, to include this in my thesis (license number; 
2501481389405). 
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Cys mutations in the proline rich region (PRR) and β-barrel domains exert effects on 
protein stability, oligomerization, and substrate transfer 
Structural models for the C-terminal domain (CTD) of VirB10 can be derived from X-ray 
structures of the H. pylori ComB10 and the E. coli pKM101 TraF proteins (15, 18). The two 
structures are comprised mainly of a β-barrel with a surface groove and both have two α-
helical projections, although the sequence compositions and the overall structures of these 
projections display important differences. For example, in the ComB10 X-ray structure, two 
monomers are aligned in a head-to-tail fashion such that the AP of one monomer sits in the 
groove formed by the β-barrel of the second (18). By contrast, in the TraF structure, 14 copies 
of TraF align such that the β-barrels form a network of interactions with each other and with 
homologs of VirB7 (TraN) and VirB9 (TraO) (15). In this structure, the AP domains from the 14 
TraF subunits assemble together as an outer membrane α-helical pore (15). Although the 
ComB10 structure is informative, we believe the TraF structure more accurately depicts the 
structure of the VirB10 protein family in complex with its partner proteins VirB7 and VirB9. 
Here, I sought to test for effects of Cys substitution mutations in the β-barrel domain and α-
helical projections on protein function and capacity to form higher-order dimers or multimers. 
No structural information is available for the PRR domain; therefore, to examine the 
contributions of this domain to oligomerization and protein function, I also introduced cysteine 
mutations along its length (Figure 3-1). Overall, I introduced 11 single cysteine replacements 
along the PRR, and β-barrel (groove and helical projections) (Figure 3-1).  
 
In our original paper describing the phenotypic consequences of the VirB10 mutations, 
the available structural model based on ComB10 (18) guided our experiments as well as data 
interpretation (24). The availability of the new TraF structure (15) allows for some 
reinterpretation of the data. Therefore, when warranted I will highlight our revised views about 
some of the earlier findings.  
 
The PRR, which extends from residues 61 – 114, contains 14 Pro residues within this 
53 residue domain, many of which are strongly conserved among VirB10 homologs. In this 
region, I generated 5 Cys substitutions of highly conserved (S61, N69, P77) and 
nonconserved (V87, P99) residues. Large deletions of this region (Δ70-92, Δ93-114, Δ70-114) 
were constructed and analyzed by V. Krishnamoorthy. Only the N69C mutant accumulated at 
low levels relative to the native protein or the other mutants, suggesting that this mutation 
could disrupt a stabilizing fold or protein-protein contact (Figure 3-4). Substitutions of any of 
the three highly conserved residues (S61, N69, P77) abolished substrate transfer and T-pilus 
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production, whereas substitutions of the weakly conserved V87 and P99 had no apparent 
effect on VirB10 function (Figure 3-4).    
 
PRR’s of proteins are implicated in mediating protein – protein interactions (55). 
Therefore, we analyzed effects of the PRR mutations on VirB10 oligomerization. We assessed 
the capacity of VirB10 to form higher-order disulfide crosslinked dimers/multimers and also to 
form precipitable complexes with the other core components VirB7 and VirB9. When 
electrophoresed under nonreducing conditions, all of the Cys-substituted PRR mutants formed 
a higher-order species of ~105-kDa, the expected size of a VirB10 dimer (Figure 3-5). I 
analyzed whether other VirB proteins might be part of this higher-order complex, but none of 
our VirB antibodies reacted with this species. These findings suggest that the higher-order 
disulfide crosslinked species are VirB10 homodimers, which is in agreement with the recent 
cryoelectron images of the pKM101 core complex showing extensive packing of TraF (VirB10) 
monomers with each other along the length of the protein (16). S. Jakubowski determined that 
all of the Cys-substituted mutants except for the unstable N69C mutant co-precipitated with 
VirB7 and VirB9; apparently, the individual PRR substitutions did not abolish either the 
capacity of VirB10 to interact with itself or with the other core subunits (24). However, S. 
Jakubowski also showed that the Δ70-92, Δ93-114, and Δ70-114 mutant proteins failed to form 
precipitable complexes with VirB7 and VirB9 (24). These findings suggest that the PRR plays 
a critical role in assembly of the VirB7/VirB9/VirB10 core complex. Further studies in the 
laboratory are currently examining the role of the PRR in assembly of the ring-shaped core 
complex.    
 
In our publication of this work, we referred to the region spanning residues 114 -173 as 
a linker region. However, the TraF crystal structure shows this region as an α-helix that makes 
extensive contacts with β-barrel domains of adjacent TraF monomers. Therefore we now 
designate this region as helix α1 or the ‘lever arm’ following nomenclature proposed by 
Waksman and his colleagues (15). We characterized only a couple mutations in this helix. 
Tyr118 is highly conserved among VirB10 homologs and, correspondingly, a Y118C mutation 
was destabilizing. Tyr118 is in a cluster of highly conserved residues (E107PRPEETPIFAY118) 
at the end of the PRR. This region is enriched in charged and aromatic residues, which I 
predict to be important for adopting a functionally important tertiary or quaternary structure. 
Consistent with this prediction, the Y118C mutant protein did not form the ~105-kDa disulfide 
crosslinked species detected for other Cys mutant proteins (Figure 3-5). S. Jakubowski 
determined that the Y118C mutant protein also did not form a precipitable complex with VirB7 
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and VirB9 (24). However, it is not possible to draw strong conclusions regarding the functional 
importance of Y118 because the Y118C mutant protein is unstable (Figure 3-4). By contrast, 
S130 is not conserved among homologs and the S130C mutation did not affect protein 
accumulation or substrate transfer (Figure 3-4). J. Kerr showed that this mutation did not affect 
T-pilus biogenesis and S. Jakubowski showed that this mutation did not affect formation of a 
precipitable VirB7/VirB9/VirB10 complex (24). Together, the limited analyses of the α1 helix 
domain allow for a general proposal that the conserved residues in this domain might play an 
important role in promoting protein – protein contacts required for machine function. This 
prediction is consistent with X-ray structural information for TraF (15). 
 
In the β-barrel, four additional regions were targeted for Cys mutational analysis, 
including: (i) the groove (V243C), (ii) the base of the barrel (T173C, N218C, D356C), (iii) a 
region we now designate as a bridging domain (D278C), (iv) the α2α3 helix-loop-helix 
(G306C, Q295C) (Figures 3-1 and 3-6). Cysteine mutations in the groove and base yielded 
reduced protein accumulation and disrupted or abolished substrate transfer and T-pilus 
assembly (Figure 3-4). Cysteine mutations in the α-helical AP and the bridging domain did not 
affect protein stability or function (Figure 3-4). Correspondingly, S. Jakubowski and J. Kerr 
showed that partial deletions of the AP and the bridging domain did not abolish protein 
function with respect to substrate transfer (24). Finally, the Cys substitutions in the AP and 
bridging domain formed higher-order disulfide crosslinked species; those in the β-barrel 
groove, base/flap regions did not form such species (Figure 3-5). The β-barrel most likely 
forms extensive homo- and heteromultimeric interactions as suggested by the recent cryoEM 
and X-ray structures of the pKM101 core complex (15, 16). However, a more extensive Cys 
mutational analysis is needed to confirm such interactions through a biochemical approach. 
My data do suggest that the bridge and AP domains of adjacent VirB10 monomers extensively 
interact, which is in agreement with predictions based on the pKM101 core complex X-ray 
structure (15). 
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Figure 3-4 Effects of Cys mutations on protein function 
Detection of 14 mutant proteins bearing Cys substitution mutations in the PRR, α1helix, and β-
barrel domains. Equivalent optical densities of induced cells were harvested and analyzed by 
SDS-PAGE and immunostaining with anti-VirB10 antibodies (Top panels). Strains: A348 (WT); 
ΔB10, PC1010; ΔB10 strains producing the Cys-substituted mutant proteins shown. DNA 
transfer was assessed by plant virulence assays. Plant leaves, K. daigremontiana, were co-
inoculated with cysteine mutant strains, A348, and ΔB10, and monitored after 4-5 weeks for 
the presence (+) or absence of tumors (-). A348 (WT) and ΔB10 served as positive and 
negative control, respectively. Virulence assays were repeated 3 times.  
 
VirB10 mutations with an asterisk (*) were constructed and introduced into A. tumefaciens by 
V. Krishnamoorthy. 
 
These data were taken and modified from (24). I have a license agreement between the 
publisher, John Wiley and Sons, to include this in my thesis (license number; 
2501481389405). 
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Figure 3-5 Mobility of VirB10 Cys mutant proteins  
Equivalent amounts of induced cells were harvested and cell extracts were resolved by 
electrophoresis through a 10% polyacrylamide gel. Cell extracts were re-suspended in 
Laemmli’s buffer with (reducing; bottom panel) and without (nonreducing; top panel) β-
mercaptoethanol (β-ME) and dithiothreitol (DTT). Protein standards (Bio-Rad) are listed at left. 
 
Strains: ΔB10, PC1010; B10, PC1010 expressing wild-type virB10; PC1010 expressing alleles 
encoding the Cys-substituted mutant proteins as shown. VirB10 mutations with an asterisk (*) 
were constructed and introduced into A. tumefaciens by V. Krishnamoorthy. 
 
These data were taken and modified from (24). I have a license agreement between the 
publisher, John Wiley and Sons, to include this in my thesis (license number; 
2501481389405).  
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Figure 3-6 Location of Cys mutations in the TraF X-ray structure 
Ribbon diagram of the TraF (VirB10 homolog) from the pKM101 X-ray crystal structure of the 
outer membrane complex (O layer). The antennae projection (AP; α2α3), groove, α1 lever 
arm, and flap/base regions are labeled. Cys substitution mutations are indicated in red with 
arrows.  
 
The TraF outer membrane structure was resolved and published by the G. Waksman 
laboratory (15). Coordinates from the published structure were accessed from the protein data 
bank (http://www.pdb.org) (accession code; 3JQO) and used with the MacPyMOL visualization 
tool to create this figure. I have an educational (Academic) subscription to use MacPyMOL 
(PyMOL Molecular Graphics System, 2006, Delano scientific, LLC., http://www.pymol.org).  
 
Mutations indicated with an asterisk (*) were constructed by Ms. V. Krishnamoorthy. 
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MPB labeling studies aimed at probing the VirB10 conformational status  
Prior studies with VirB10 identified a conformational switch upon sensing of ATP 
hydrolysis from inner membrane associated VirB11 and VirD4 (20). This conformational switch 
was detected as a change in susceptibility to the Streptomyces griseus protease such that 
VirB10 (48-kDa) was degraded to a (40-kDa) species when produced in wild-type cells but 
was not degraded when produced in ATP-depleted cells or virD4 or virB11 null mutant strains 
(20). The conformational switch was postulated to be required for stable interaction or 
productive channel formation with the outer membrane subunits VirB7 and VirB9 (20). To gain 
further evidence for the proposed energy dependent conformational switch, I assayed for 
changes in accessibility of Cys residues introduced along the length of VirB10 in different 
mutant strains. This study utilized the single Cys residue replacements introduced throughout 
the periplasmic domains of VirB10 (described above). Initially, I compared the Cys 
accessibility profiles of the Cys-substituted VirB10 derivatives when synthesized in a non-polar 
virB10 deletion mutant PC1010 (19) (produces all of the VirB proteins) and a ΔvirB operon 
mutant PC1000 (28) (lacks the other VirB subunits).   
 
An important caveat to this analysis was that native VirB10 as well as the Cys-
substituted VirB10 derivatives accumulated at lower levels in the ΔvirB operon mutant 
compared with the ΔvirB10 mutant. This was most likely due to the absence of stabilizing 
interactions in the absence of other channel subunits. When normalized for VirB10 levels, 
however, some potentially interesting differences in MPB labeling were observed. Specifically, 
among all of the Cys-substituted derivatives examined, only those with mutations in (D278C, 
G306C, Q295C) or near (V243C) the AP domain were more strongly labeled in the ΔvirB10 
background as compared with the ΔvirB background (Figure 3-7). Residue substitutions in the 
PRR and α1 domains, as well as a few residue substitutions in the β-barrel, showed similar 
levels of labeling in both genetic backgrounds. These results are compatible with predictions 
from the TraF structural studies (15) that the outer membrane pore formed by the AP domain 
of VirB10-like TraF undergoes conformational transitions during substrate translocation or T-
pilus biogenesis.  
 
At this time, we do not know whether the observed differences in MPB labeling of the 
AP Cys mutations are due to a lack of energy activation or improper folding of VirB10 in the 
absence of partner channel subunits. Further investigations of the proposed energy-mediated 
dynamic activity of the AP will require parallel MPB labeling studies of the Cys-substituted 
VirB10 mutants produced in strains lacking one or more of the VirB4, VirB11 or VirD4 
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ATPases. This will require construction of additional strains, e.g., the appropriate nonpolar 
deletion mutants (e.g., ΔvirB10/ΔvirD4, ΔvirB10/ΔvirB4, ΔvirB10/ΔvirB11) expressing virB10 
alleles encoding the VirB10 Cys mutants without or with wild-type or mutant ATPases.   
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Figure 3-7 MPB Labeling profiles for VirB10 Cys mutant proteins expressed in a ΔvirB10 
versus a ΔvirB1-B11 (ΔvirB operon) strain background  
Top panel: MPB labeled proteins separated on a 12.5% polyacrylamide gel followed by 
transfer to nitrocellulose membranes and incubated with an avidin-HRP antibody, developed 
with enhanced chemiluminescence reagents. Bottom panel: total cell extracts from listed 
strains showing the relative steady state protein levels in the different strain backgrounds.  
 
Strains: WT, A348; ΔB10, PC1010 (19); ΔvirB, PC1000 (28). VirB10 mutations with an asterisk 
(*) were constructed by V. Krishnamoorthy. 
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Further characterization of the AP domain by cysteine mutational analysis  
Two intriguing observations prompted us to initiate a further study of the VirB10 AP 
domain. First, the X-ray crystal structure of a homolog of VirB10, TraF, of the pKM101 
conjugation T4SS identified the AP domain as forming a presumptive outer membrane pore 
(15). Recall that the overall X-ray structure of the pKM101 core complex presented as a 
heterotrimeric complex in a 1:1:1 ratio of TraF (VirB10), TraO (VirB9), and TraN (VirB7) with 
14 copies of each subunit (15). The TraF AP is postulated to span between two conserved 
residues, Arg306 and I355, which for VirB10 correspond to residues Arg284 and I335. If the 
VirB10 AP forms an outer membrane pore, it might form close contacts with translocating 
substrates, the T-pilus, or both. Additionally, a flexible loop domain positioned between the two 
membrane spanning α-helices should be surface-exposed. To test these predictions, I 
introduced 7 Cys substitution mutations along the length of the VirB10 AP with a goal of 
assaying for intra- and intermolecular disulfide crosslinks and accessibility of the engineered 
Cys residues to membrane-impermeable, thiol-reactive reagents. As with the other Cys 
mutational analyses, these studies were carried out in collaboration with another graduate 
student, J. Kerr, and a postdoctoral fellow, S. Jakubowski.  
 
The positions of the 7 Cys residues as well as two Cys substitution mutations that V. 
Krishnamoorthy previously constructed in the AP (Q295C and G306C) are shown in Figures 3-
1 and 3-6. Three Cys mutations (M289C, Q295C, F298C) were in the putative membrane-
spanning α2-helix, 4 mutations (S302C, G306C, N315C, F317C) were in the intervening loop, 
and 2 mutations (L329C, T332C) were in the putative membrane-spanning α3-helix (Figure 3-
6).     
 
The initial studies assayed for effects of Cys mutations on protein stability, substrate 
transfer and T-pilus biogenesis. The 7 Cys mutant proteins accumulated at abundant levels, 
comparable to the level of the native protein when produced in trans from an IncP replicon 
(Figure 3-8). Nearly all of the mutant proteins supported efficient levels of substrate transfer as 
well as T-pilus biogenesis, as monitored by T-pilus colony and shear assays (Figure 3-8). The 
one exception, T332C, supported efficient substrate transfer, but only low levels of T-pilus 
compared with the other mutant proteins. Effects of the Q295C and G306C mutations were 
reported previously (24); these mutations phenocopied the other 7 Cys AP mutations with 
respect to effects on protein stability and function.    
 
 49 
The functionality of the Cys mutant proteins enabled further studies aimed at testing for 
interactions with other channel subunits or translocating substrate. I first assayed for formation 
of disulfide crosslinked complexes by maintaining proteins under nonreducing conditions 
during cell lysis and gel electrophoresis. Interestingly, all Cys mutant proteins formed high-
molecular weight species of estimated sizes (~100 to 105-kDa) expected of a VirB10 
homodimer (Figure 3-8). Antibodies to other VirB subunits and to the protein substrate VirE2 
did not react with the higher-order species. Further studies are being carried out by S. 
Jakubowski and J. Kerr to test for disulfide crosslinking with secretion substrates such as VirF 
and VirD2. However, in view of the pKM101 X-ray structure showing close packing of the TraF 
AP domains in the presumptive outer membrane pore (15), it seems most probable that Cys 
residues of juxtaposed AP domains form disulfide bridges to generate crosslinked 
homodimers.   
 
Next, I tested for surface accessibility of the AP Cys residues by assaying for reactivity 
with the thiol reactive compound MPEG. MPEG (5-kDa) is a sulfhydryl reactive maleimide that 
is too large to pass through outer membrane pores and therefore covalently reacts with 
accessible thiol groups located on the cell surface (25, 56, 57). Chemical reactivity with MPEG 
results in a 5-kDa shift in the apparent molecular size of a protein upon electrophoresis 
through a SDS-polyacrylamide gel. Interestingly, I was unable to detect reactivity of any AP 
Cys residue with MPEG. Previously, our laboratory used MPEG to gain evidence for surface 
accessibility of a domain of VirB9 (56). It is possible the Cys residues of the VirB10 AP are 
buried in the pore or another protein – protein interface, and further tests for AP surface 
accessibility are in progress. 
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Figure 3-8 Effects of VirB10 AP Cys mutations on protein function  
A.  T-pilus production was affirmed through surface and shear assays. Protein 
accumulation was determined by western blot analysis with anti-VirB2 and anti-VirB10 
antibodies, as listed. DNA substrate transfer was assessed by the ability of strains to incite 
production of tumors (+) or no tumors (-) on K. daigremontiana plant leaves. Virulence is 
reported in relation to WT (+++; WT virulence) and ΔB10 ( - ; avirulent). 
B. Migration of VirB10 Cys mutants in 10% polyacrylamide gels under nonreducing 
conditions, monitored by immunoblotting with anti-VirB10 antibodies.  
 
Strains: WT, A348; ΔB10, PC1010; ΔB10 strains producing Cys mutant proteins as listed.  
 
Colony (surface) assays for strains producing VirB10 derivatives with Cys substitutions in the 
AP domain were replicated by graduate student Jennifer E. Kerr.  
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Discussion 
Roles of the N-terminal cytoplasmic and transmembrane domains on protein function 
The VirB proteins assemble as a transenvelope secretion channel and an attachment 
organelle called the T-pilus (4). This study was aimed at defining the contributions of various 
domains of VirB10 to assembly of these surface organelles. I constructed and characterized 
Ala-Cys insertion mutations along the N-terminal cytoplasmic and putative transmembrane 
domains of VirB10, and Cys substitution mutations of conserved and nonconserved residues 
in the periplasmic domains. As these studies were proceeding, structures of the VirB10 
homologs ComB10 and TraF in complex with other core components were solved by X-ray 
crystallography and cryoelectron microscopy (15, 16, 18). These structures guided further 
experimentation and also enabled refined interpretations of our existing data. 
 
Our mutational analyses confirmed the importance of the N-terminal domains for 
VirB10 function. Although VirB10 accommodated i2 mutations at 5-residue intervals along the 
cytoplasmic domain, deletion of the N-terminal 18 residues disrupted protein function at least 
to some extent (24). V. Krishnamoorthy constructed a larger deletion mutation of the first 46 
residues, this mutant protein did accumulate, however, did not support substrate transfer, T-
pilus biogenesis, and interaction with VirD4 (24). The N-termini of VirB10 homologs in A. 
tumefaciens and related species in the family Rhizobaceae are highly conserved (see below; 
Figure 4-1). It seems reasonable that the cytoplasmic domain contributes to the establishment 
of productive contacts with other channel subunits. Although the i2 insertions apparently did 
not disrupt critical contacts, it is noteworthy that a swap of the N-terminal cytoplasmic and TM 
domains of the cell division protein FtsN for the corresponding region of VirB10 abolished 
protein function (Figure 4-6). By contrast, as discussed further in Chapter 4, a swap of just the 
FtsN TM domain for that of VirB10 did not abolish activity. These findings provide further 
evidence for the importance of the N-terminal cytoplasmic domain for VirB10 function.  
 
With respect to the TM domain, the i2 mutations did not disrupt substrate transfer or 
formation of a precipitable complex with the VirD4 ATPase (24). These findings suggest that 
the mutant proteins retained the capacity to sense ATP energy use by VirD4 and VirB11 and 
support substrate transfer. By contrast, i2 mutations at residues 35, 40, 45, had either reduced 
or no observable T-pili (24). These mutations were designated “uncoupling” mutations 
because they selectively blocked T-pilus biogenesis without affecting substrate transfer. 
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The isolation of VirB10 “uncoupling” mutations adds to a list of such mutations isolated 
in other VirB subunits, including the VirB11 ATPase (38, 58), polytopic VirB6 (59), outer-
membrane-associated VirB9 (60), and VirB2 pilin (61). Although the identification of such 
mutations has led to a proposal that the VirB subunits alternatively assemble as a secretion 
channel or the T-pilus, the underlying mechanism of action(s) of “uncoupling” mutations 
remains unknown. For “uncoupling” mutations in the other VirB subunits, it has not been 
possible to predict effects on protein structure or oligomerization. By contrast, the isolation of 
“uncoupling” mutations in the VirB10 TM domain allows for the first time the development of 
testable models regarding the contributions of a discrete domain specifically for T-pilus 
biogenesis. For example, the i2 mutations are predicted to generate a shift in the register of 
the TM helix; this in turn could disrupt helix – helix interactions that are required for T-pilus 
assembly but not for elaboration of a functional secretion channel.  
 
The T-pilus is a polymer assembled from VirB2 pilin (4). Our working model is that 
mature VirB2 pilin accumulates in the inner membrane as a pool for polymerization upon 
receipt of an unspecified signal. For polymerization, VirB2 must first be extracted from the 
inner membrane, presumably through an energy dependent process involving ATP energy 
and/or an electrochemical gradient. The VirB10 TM mutations could exert a direct block in the 
T-pilus assembly pathway by impeding the early pilin dislocation or polymerization reactions. 
In view of the CryoEM structure of the pKM101TraF(VirB10)/TraN(VirB7)/TraO(VirB9) core 
complex, it is reasonable to suggest that a VirB10/VirB7/VirB9 complex serves as a scaffold 
for T-pilus assembly. If so, an early step in polymerization of the T-pilus might involve 
translocation of VirB2 pilin through the inner membrane into the core chamber. Accordingly, 
VirB10 TM helix-helix interactions - either homo- or heterospecific - might directly impact the 
passage of the pilin into the core chamber. An alternative model is that VirB10 TM helix – helix 
interactions influence the overall structure or dynamic activity of the T-pilus assembly platform. 
According to this model, the helix-helix contacts might act indirectly by modulating the 
activities of other domains or subunits involved in T-pilus biogenesis. In Chapter 4, I 
summarize results of my studies further exploring the role of the VirB10 TM domain in T-pilus 
biogenesis. 
 
Besides mediating protein – protein contacts required for machine assembly or 
function, the TM domain likely anchors VirB10 in the inner membrane. However, the question 
of whether VirB10 stably or transiently associates with the inner membrane is raised through 
investigations of the energy transducer TonB. In early studies of TonB mutants, Cys residues 
engineered in the putative cytoplasmic domain were MPB-labeled upon treatment of intact 
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cells (54). These findings led to formulation of the ‘shuttling’ model, whereby the energy-
activated form of TonB resulting from sensing of the proton motive force was dislocated from 
the inner membrane and subsequently delivered to the outer membrane where it activates 
translocation of small molecules through cognate transporters (54). More recent studies 
appear to have discounted this early ‘shuttling’ model for TonB (62), but the idea prompted me 
to assay for a stable vs transient association of the VirB10 energy sensor with the inner 
membrane. I was unable to detect any labeling of Cys residues engineered into the 
cytoplasmic or TM domains of VirB10 upon treatment of intact cells. By contrast, Cys residues 
in the cytoplasmic domain were labeled upon treatment of cell lysates, whereas Cys residues 
in the putative TM domain failed to label under any condition, strongly indicating that these 
residues are buried in the hydrophobic lipid bilayer and inaccessible to thiol-reactive reagent. 
Together, these data confirm a bitopic membrane topology for VirB10 and also argue against a 
possible energy-mediated ‘shuttling’ mechanism. Our topology model indicates that the TM 
domain spanning residues ~30-50 stably anchors VirB10 in the inner membrane and the bulk 
of the rest of the protein is periplasmic.  
 
Role of the PRR and α1 helix on protein function and complex formation 
Prolines in protein domains can impart unique conformational restrictions and can 
result in extended protein structures (63, 64). This property is accredited to the unusual bond 
between the proline side-chain and the backbone amide position (55). Proline-rich regions 
(PRR’s) also can mediate protein – protein interactions (55, 65). We postulated that the VirB10 
PRR is required for extension of the protein from the inner to outer membranes and also that 
PRR’s of adjacent subunits interact in the assembled core complex. Consistent with these 
predicted functions, V. Krishnamoorthy and S. Jakubowski determined through 
characterization of deletion mutations that the VirB10 PRR is essential for VirB10 function and 
also for a VirB10 interaction with the VirB7/VirB9 heterodimer (24). My broad goal was to 
introduce Cys residues along the PRR to assay for disulfide crosslinking with partner proteins. 
Since we also had determined that VirB10 undergoes a conformational switch in response to 
sensing of ATP energy use by inner membrane ATPases, I also sought to determine whether 
PRR Cys residues display changes in MPB labeling in different mutant strain backgrounds.  
 
The VirB10 PRR (residues ~ 61-114) is ~ 28 % Pro, and also has two Pro-Pro 
dipeptides (Pro81-Pro82, Pro98-Pro99) which tend to restrict flexibility even more than individual 
prolines (55). As might be expected, Cys substitutions of conserved residues in the PRR 
abrogated protein function, whereas substitutions of nonconserved residues did not affect 
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function. Regardless, all of the Cys substitutions in the PRR and newly-designated ‘lever arm’ 
formed disulfide-crosslinked species of similar molecular size (~105 kDa) when cell extracts 
were electrophoresed under nonreducing conditions (Figure 3-5). The estimated molecular 
size of the crosslinked species and apparent absence of other VirB proteins migrating at this 
position in the nonreducing gels suggests the Cys-substituted VirB10 derivatives crosslinked 
to form homodimers. The propensity of both the PRR and the lever arm to mediate self-
association of adjacent VirB10 monomers fits with the structural predictions derived from the 
pKM101 crystallography and cryoelectron microscopy images (15, 16).  
 
A couple of mutations were also introduced into the α1 helical lever arm of VirB10, a 
region spanning residues 114 – 173. As mentioned above, this region was originally thought to 
join the PRR with the β-barrel identified in the ComB10 X-ray structure. In the recent TraF X-
ray structure, this region comprises an essential feature of the core complex. It extends 
laterally from the β-barrel of one monomer to establish contacts not only with the adjacent β -
barrel but also with the next β-barrel in the complex (15). The lever arms thus overlap laterally 
to form a structural ‘belt’ surrounding the core complex. If this structure is correct, one might 
anticipate that Cys residues in the lever arm would form intermolecular disulfide crosslinks. 
 
Interestingly, the Cys substitutions in the PRR and lever arm were MPB-labeled to 
similar extents when the mutant proteins were produced in the presence or absence of other 
VirB proteins. These observations allow only for a limited conclusion that the positions marked 
by these Cys substitutions are not buried in a structural fold or protein – protein interface in 
these two genetic contexts. Further studies are needed to determine whether Cys substitutions 
of other residues in the PRR or lever arm would display differences in MPB labeling in other 
virB mutant backgrounds.   
 
VirB10, the T4SS outer membrane pore 
The X-ray structure of the pKM101 core complex highlights the structural importance of 
the β-barrel, as well as the TraF (VirB10) AP domain which appears to assemble as an outer 
membrane α-helical pore (15). In view of the extensive network of intersubunit contacts, it is 
not surprising that Cys substitutions of β-barrel residues did not label efficiently with MPB and 
also did not form higher order species when the mutant proteins were subjected to 
nonreducing gel electrophoresis (Figure 3-3 and 3-5). Moreover, Cys substitutions of β-barrel 
residues tended to abrogate protein function, consistent with the notion that native residues at 
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these positions contribute to folding of the β-barrel domain or oligomerization. By contrast, Cys 
substitutions in the AP did not disrupt protein function (Figure 3-4). These residues also were 
readily labeled by MPB and formed higher order disulfide crosslinked species when 
maintained under nonreducing conditions (Figure 3-3 and 3-5). These findings are compatible 
with the crystallographic data indicating that the AP extends from the β-barrel and that AP’s of 
adjacent monomers in the core complex form close contacts in the presumptive outer 
membrane pore (15). Also of considerable interest, the AP Cys residues were efficiently MPB-
labeled when the mutant proteins were synthesized in the presence of other VirB subunits, but 
only weakly labeled in the absence of other VirB subunits (Figure 3-7). These observations 
suggest that VirB10 complex formation with other VirB partner proteins is required for proper 
folding of the AP and, possibly, assembly of the outer membrane pore.   
 
Our early finding that VirB10 undergoes a conformational switch upon sensing of ATP 
energy consumption by the VirD4 and VirB11 ATPases led to a model that energy activation 
serves to induce formation or opening of the outer membrane pore (20). Results of these initial 
MPB labeling studies are compatible with this model, but further MPB-labeling studies are 
needed to explore the contributions of the inner membrane ATPases to the overall structure of 
the VirB10 AP domain.  
 
A central question emerging from the pKM101 core crystal structure is whether the 
VirB10 AP extends entirely across the outer membrane. Since the structure was generated for 
a complex of only 3 of the 11 T4SS subunits, it is conceivable that the AP is very differently 
configured in the fully assembled channel. I attempted to detect surface accessibility of the 
VirB10 AP by treatment of intact cells with the thiol reactive reagent MPEG. However, I was 
unable to detect a ~5-kDa shift of the AP Cys mutants, suggesting that the AP does not extend 
entirely across the outer membrane or that the AP was buried by another protein, e.g., VirB2, 
VirB5, or some unspecified surface molecule, e.g., LPS, cellulose. Another possibility is that 
the AP is transiently surface-exposed or exposed only upon establishment of stable mating 
junctions with target cells. Besides the two Cys substitutions originally introduced in the AP 
region (D278C, G306C), I have recently constructed an additional 7 Cys replacements. My 
initial studies have shown that none of the mutations affect protein function and all of them 
form higher-order crosslinked species in nonreducing conditions (Figure 3-8). This collection of 
AP mutations will allow for expanded tests of AP domain interactions, structural flexibility, and 
surface accessibility. 
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In summary, my findings support a general model that VirB10 forms a structural 
scaffold for assembly of the secretion channel or T-pilus.  Of most interest, the VirB10 TM 
domain appears to play a critical role in T-pilus biogenesis, and further studies focused on 
exploring this function are described in more detail in the following chapter. Results of the 
mutational, MPB labeling, and crosslinking studies support a model that VirB10 stably 
associates with the inner membrane and extends across the outer membrane to make critical 
contacts with outer membrane subunits VirB7 and VirB9. The initial studies of AP Cys 
mutations also are consistent with a model that this domain is structurally dynamic. Ongoing 
studies are exploring the surface accessibility of the AP region to test the hypothesis that this 
region functions as an outer membrane pore. 
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Chapter 4. VirB10 TM Domain: A Leucine Interaction Motif is Necessary for T-pilus 
Formation but not for Substrate Transfer  
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Introduction 
The VirB/VirD4 type IV secretion system (T4SS) of Agrobacterium tumefaciens 
translocates DNA and protein substrates to plant and other eukaryotic cells by a process 
requiring direct cell-cell contact (1). The eleven VirB proteins and the VirD4 substrate receptor 
direct assembly of the T4SS channel that spans the Gram-negative cell envelope as well as 
an extracellular filamentous structure termed the T-pilus. All of the VirB proteins are required 
for channel and T-pilus formation, and their general functions can be subclassified as: i) 
energetic components (VirD4, VirB4, VirB11 ATPases), ii) core channel subunits (VirB6, VirB7, 
VirB8, VirB9, VirB10), and iii) T-pilus or other structural components (VirB1, VirB2, VirB3, 
VirB5) (4). Early studies of this system defined pairwise contacts and subcellular localizations 
of the VirB subunits, supplying a general view of the VirB/VirD4 channel architecture. Very 
recently, however, a core complex from a related T4SS encoded by the conjugative plasmid 
pKM101 was resolved by cryoelectron microscopy (Cryo-EM) and X-ray crystallography (15, 
16). Most notably, the emerging structural information highlights the importance of three 
subunits, bitopic protein VirB10 and two outer membrane-associated subunits VirB7 
lipoprotein and VirB9. Fourteen copies each of the pKM101-encoded homologs of VirB7, 
VirB9, and VirB10 interact to form a large (~1.5-MDa) ring-shaped complex that spans the 
entire cell envelope (16). The complex has a central chamber of sufficient size to 
accommodate other VirB subunits. These structural features, in addition to observed 
stabilizing functions of these core subunits on other machine components, have prompted a 
model in which the VirB7/VirB9/VirB10 core complex serves as a scaffold for assembly of the 
translocation channel and the T-pilus.    
 
A particularly interesting feature of the core complex is that VirB10-like TraF spans the 
entire cell envelope (23). As discussed earlier, VirB10 has several discrete domains that 
localize in different cellular compartments: i) an N-terminal cytoplasmic domain (residues ~1-
30), ii) a transmembrane TM domain (residues ~30-50), iii) a periplasmic proline-rich region 
(PRR, ~61-114), iv) a periplasmic β-barrel (~115-377), positioned in the periplasm near the 
outer membrane, with 2 α-helical extensions termed the lever arm (~114-173) and the 
antennae projection (AP, ~285-335) (15, 24). In the TraF structure, the AP is depicted as 
forming an α-helical pore at the outer membrane (15).  
 
Mutational studies in our laboratory supplied evidence that the two membrane-
spanning domains, the inner membrane TM domain and the presumptive outer-membrane-
spanning AP, are critical for VirB10 function (24). While our deletion analyses have 
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established that both domains are essential for both substrate transfer and T-pilus production, 
certain mutations in these domains selectively abolished T-pilus biogenesis without blocking 
substrate transfer. V. Krishnamoorthy showed that a partial AP deletion conferred this 
phenotype, and I showed that an Ala-Cys insertion (i2) at residue 40 corresponding to the 
middle of the TM domain abolished T-pilus production (24). Moreover, i2 mutations at residues 
35 and 45 conferred reduced levels of T-pilus without affecting substrate transfer (24). Our 
ability to isolate transfer-positive, pilus-minus (Tra+,Pil-) “uncoupling” mutations is of 
considerable interest in that it establishes that this T4SS system mediates substrate transfer in 
the absence of detectable T-pili. More specifically, however, their isolation in the TM and AP 
domains suggests that both of these putative membrane-spanning regions of VirB10 
contribute in distinct ways to channel and T-pilus assembly. 
 
In this study, I focused on defining the mechanism of action of the VirB10 TM domain 
in mediating T-pilus biogenesis. My overarching hypothesis is that the VirB10 TM helix 
interacts with one or more TM helices and that such helix-helix contact(s) are critical for T-pilus 
assembly but not for substrate transfer. VirB10 TM helices might self-associate, forming 
homodimers or multimers, or form stable or transient interactions with membrane helices of 
other channel subunits. My proposal that the VirB10 TM domain multimerizes is supported by 
several observations. First, the recently published images of the pKM101 core complex 
obtained by cryoelectron microscopy and X-ray crystallography present evidence that 14 
copies of TraF form the outer wall of the core channel (15, 16). Whereas the core complex X-
ray structure identifies extensive contacts among β-barrel domains of adjacent TraF subunits, 
the cryoEM images also suggest that the PRR’s and, possibly, the TM helices of adjacent 
TraF subunits interact (16). As discussed in Chapter 3, results of my disulfide crosslinking 
experiments support the idea that adjacent PRR’s dimerize. The association of VirB10 TM 
helices might be important for stabilization of the core complex ring structure at the inner 
membrane.   
 
Second, in the pKM101 core complex structure resolved by CryoEM, the diameter of 
the chamber interior at the inner membrane is ~55 Å, a dimension of sufficient size to 
accommodate other VirB channel subunits (16). By use of a substrate trapping assay, our 
laboratory previously reported that two other inner membrane subunits, polytopic VirB6 and 
bitopic VirB8, form close contacts with translocating DNA substrates (17). If our model that the 
core complex houses the translocase is correct, both VirB6 and VirB8 should assemble within 
the core chamber at the inner membrane. It is reasonable to predict that the VirB10 helices 
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would interact with one or both of these subunits. As discussed further below, the VirB10 
helices might also interact dynamically with the VirB2 pilin, or with other subunits, during early 
stages of T-pilus biogenesis. 
 
Finally, on examination of the VirB10 TM domain sequence, I identified at least two 
possible dimerization motifs. The first is a GXXXA (GA4) motif, which, like the similar GXXXG 
(GG4) motif, is a common dimerization motif among TM helices of membrane proteins (66-69). 
The second is a set of two Leu(Ile) zipper motifs which also have been shown to mediate 
dimer formation among soluble proteins as well as some eukaryotic and viral membrane 
proteins (70-74). Of interest, the 40.i2 mutation that selectively disrupts T-pilus biogenesis is 
positioned both within the GA4 and Leu(Ile) zipper motifs; accordingly, this mutation might 
disrupt one or both of these interaction motifs. 
 
In this study, I designed mutations to test for the contributions of putative dimerization 
motifs to VirB10 function. My findings support a model that one Leu zipper motif is important 
for assembly of T-pili. This motif, contributes to weak self-association of VirB10 TM helices.  
Results 
The GA4 dimer motif is dispensable for VirB10 function 
On the basis of my MPB labeling data, I predict the VirB10 TM domain spans residues 
~30-50 (SQKLIVGGVVLALSLSLIWLG). This sequence, including the GA4 motif, is highly 
conserved among VirB10 homologs identified in other members of the Rhizobiaceae (Figure 
4-1). In fact, additional conserved residues form GG4 or GA4 dimer interfaces  
(LIXXGVXXG/AVXXT) (66, 75). In VirB10 and its close homologs, these additional residues 
(33-LIVGGVVLALSLS-45) are also present (Figure 4-1). In the well-characterized glycophorin 
A, this extended GG4 motif has been shown to promote lateral interactions between adjacent 
TM domains (66, 76, 77).   
 
To evaluate the importance of the GA4 motif for VirB10 function, I introduced isoleucine 
(Ile) residue replacements to create steric clashes in the putative TM-TM packing interface 
(Figure 4-2). Elsewhere, it has been shown that corresponding mutations of GG4 or GA4 TM 
domains of GpA or other dimerizing proteins abolishes dimerization (26). These mutant 
proteins (G37I and A41I) were subsequently tested for effects on protein accumulation, 
substrate transfer and T-pilus biogenesis. Both GA4 mutant proteins accumulated at abundant 
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levels when produced in a ΔvirB10 strain, suggesting that the mutations do not affect protein 
stability (Figure 4-2). Additionally, the corresponding mutant strains produced abundant levels 
of T-pili as judged by detection of VirB2 pilin on the cell surface by colony immunoblotting and 
in high-molecular-weight material recovered by shearing of surface proteins and structures 
(Figure 4-2). I further tested for effects of the mutations on T-DNA transfer to K. 
diagremontiana leaves with a virulence assay and conjugative transfer of a mobilizable IncQ 
plasmid to agrobacterial recipient cells (Figure 4-2). Overall, the mutant strains showed only a 
slight reduction in virulence and IncQ plasmid transfer as compared to the wild-type control 
strain. Given that these substitutions do not exert pronounced effects on the capacity of VirB10 
to support either T-pilus production or substrate transfer, we conclude that this GA4 motif is not 
a functionally important motif. Below, I provide additional evidence that the GA4 motif does not 
contribute to formation of VirB10 TM-TM dimers. 
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Figure 4-1 VirB10 TM aligned with GA4 consensus motif and Pro Dom analysis 
A. Diagram illustrating sequence similarity between VirB10 GA4 motif and the glycophorin 
A (GpA) GG4 motif. 
B.  Pro Dom analysis (78) (http://prodom.prabi.fr/prodom.html) identified sequence 
conservation among VirB10 homologs. Invariant residues are upper cased and red, residues 
of similar homology are lower cased and blue.  
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Figure 4-2 Effects of GA4 point mutations on protein function 
A.  Sequence alignment between the TM domain of VirB10, showing residues 30-50, and 
the consensus sequence for GG4 motif. Downward arrows indicate residue position of 
isoleucine (Ile) replacements engineered in the TM domain of VirB10.  
B.  From top, T-pilus production by strains producing the GA4 mutant proteins. VirB2 
surface blot assays, T-pilus isolation (shear) assays, total cellular levels for VirB2 and VirB10. 
Immunodetection was with anti-VirB2 or anti-VirB10 antibodies as indicated at left of the panel.  
C.  Conjugative DNA transfer efficiencies and virulence data for infected K. 
diagremontiana leaves are shown for listed strains. Conjugative IncQ plasmid transfer (white 
bars) frequencies are reported as the number of transconjugants per donor cell. Virulence 
(black bars) is reported in relation to WT (+++; WT virulence) and ΔB10 ( - ; avirulent). 
 
Strains: WT, A348; ΔB10, PC1010; G37I and A41I, PC1010 producing VirB10 mutants with Ile 
substitutions at positions 37 and 41 in the TM domain.  
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Mutations in TM leucine residues abolish T-pilus formation 
  The VirB10 TM domain also has two putative Leu(Ile) zipper motifs, designated LZ1 
(L33, L40, I47) and LZ2 (V35, L42, L49). Leu zippers have a characteristic Leu or Ile heptad 
motif (abcdefg)n that forms an α-helix TM-TM packing interface (79-81). Accordingly, a heptad 
wheel shows the two Leu clusters are situated on opposite faces of the α-helix (Figure 4-3). In 
view of the pKM101 CryoEM images presenting evidence that TM domains of the VirB10-like 
TraF form a 14-membered ring structure at the inner membrane (16), I sought to test whether 
VirB10 might undergo lateral TM-TM packing interactions required for substrate transfer and/or 
T-pilus biogenesis. 
 
I created single and triple Leu to Ala substitutions in the putative LZ1 and LZ2 motifs  
(Figure 4-4 and 4-5). All mutant proteins accumulated at abundant levels and there was little 
accumulation of proteolytic degradation products. Interestingly strains with LZ1 mutations 
elaborated reduced levels of T-pilus, as monitored by colony immunoblot and shear assays 
using anti-VirB2 antibodies. The L33A and L40A mutant strains accumulated detectable levels 
of extracellular VirB2 indicative of some T-pilus production, whereas VirB2 was barely or not 
detectable in the extracellular fractions from the I47A mutant and the triple Ala mutant (Figure 
4-4). Together, these data indicate that the Leu residues comprising the putative LZ1 
contribute in some way to T-pilus production (Figure 4-4).   
 
  In contrast to the effects of the Ala substitution mutations on T-pilus production, strains 
producing the L33A or L40A mutations exhibited wild-type levels of virulence on plants and 
interbacterial IncQ plasmid transfer (Figure 4-4). The I47A mutant strain also transferred the 
DNA substrates at near wild-type levels, although the triple Ala substitution mutant showed a 
reduction of ~2 orders of magnitude in IncQ plasmid transfer efficiencies (Figure 4-4). Even so, 
the triple mutant transferred DNA substrates well above background levels indicating that the 
putative LZ1 is not absolutely essential for assembly of a functional translocation channel.   
 
I also tested for effects of Ala substitution mutations of the putative LZ2 motif (V35, 
L42, L49) (Figure 4-5). In contrast to the LZ1 analyses, the single and triple Ala substitution 
mutations exerted no discernible effects on VirB10 protein accumulation or the capacity of 
mutant strains to elaborate T-pili or transfer DNA substrates (Figure 4-5). These results 
indicate that the putative LZ2 motif (V35, L42, L49) does not contribute in detectable ways to 
VirB10 function.  
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Figure 4-3 VirB10 TM aligned in a heptad repeat to identify possible Leu zippers 
Helical wheel diagram for the VirB10 TM sequence identifying two possible Leu zippers; LZ1 
(L33, L40, I47; red) and LZ2 (V35, L42, L49; blue). 
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Figure 4-4 Effects of Ala substitutions in the putative LZ1 motif (L33, L40, I47)  
A. Sequence of the TM domain of native VirB10 from residues 30 to 50. Downward 
arrows indicate Ala substitutions.  
B. From top: T-pilus production by VirB2 surface and shear assays. Total cellular levels of 
VirB2 and VirB10. Development was with anti-VirB2 or anti-VirB10 antibodies as listed to the 
left of panel.  
C. DNA substrate transfer efficiencies and virulence data. Conjugative IncQ transfer 
(white bars) is presented as the number of transconjugants per donor cell. Virulence (black 
bars) is reported on a scale ranging from WT virulence (three pluses) to avirulent (minus sign). 
 
Strains: WT, A348; ΔB10, PC1010; PC1010 producing mutant proteins as listed.  
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Figure 4-5 Effects of Ala substitutions in the putative LZ2 motif (V35, L42, L49)  
A. Sequence of the TM domain of wild type VirB10 (residues 30 to 50). Downward arrows 
indicate positions of Ala substitution(s)  
B. From top: T-pilus production by VirB2 surface and shear assays. Total cellular levels of 
VirB2 and VirB10. Immunoblots were developed with anti-VirB2 or anti-VirB10 antibodies as 
listed to the left of panel.  
C. DNA substrate transfer efficiencies and virulence data. Conjugative IncQ transfer 
(white bars) is presented as the number of transconjugants per donor cell. Virulence (black 
bars) is reported on a scale of three pluses for wild-type virulence to a minus sign for 
avirulence. 
 
Strains: WT, A348; ΔB10, PC1010; PC1010 producing mutant proteins as listed.  
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VirB10 TM domain substitutions: an FtsN TM domain swap 
The above findings suggest that the putative LZ1 motif, but not the GA4 or LZ2 motifs, 
contributes to VirB10 function. The LZ1 Ala substitution mutations disrupted T-pilus biogenesis 
and the triple Ala mutation also conferred diminished substrate transfer. To test a model that 
the putative LZ1 motif might participate in assembly of TM-TM helix homo- or heterodimers 
required for protein function, I constructed two TM domain swaps. The first involved 
replacement of the VirB10 TM domain with that of a heterologous TM domain that retains a 
putative LZ1 zipper motif but differs in other residues. This was achieved by replacing residues 
35-50 of VirB10 with the corresponding region of the bitopic protein FtsN. FtsN functions in 
stabilization of FtsZ and other subunits of the divisome at the site of cell division (82). FtsN 
derivatives bearing substitutions of its TM and N-terminal cytoplasmic domains with 
corresponding domains from heterologous bitopic proteins were reported to function in cell 
division (83), although a more recent study provided genetic evidence for the involvement of 
one or both FtsN domains for divisome assembly (84).  
 
The chimeric VirB10 TM domain is composed of a putative LZ1 motif (L33, L40, L47) 
which as shown for native VirB10 forms a poly Leu face in a helical wheel representation 
(Figure 4-3). The VirB10/FtsNTM chimeric protein accumulated at abundant levels, although a 
proteolytic breakdown product of ~40 kDa that is occasionally detected with the native protein 
was also abundant (Figure 4-6). Nevertheless, the chimeric protein supported near wild-type 
levels of T-pilus production as monitored by both colony immunoblot and shear assays. Of, 
further interest, VirB10/FtsNTM also supported wild-type levels of substrate transfer as 
monitored by virulence on plants (Figure 4-6).   
 
I next sought to determine if the putative LZ1 motif is responsible for the functionality of 
the VirB10/FtsNTM chimeric protein. Two mutant proteins were constructed, one with a 
Leu47Ala substitution and a second with Ala substitutions at Leu33, Leu40, and Leu47 (Figure 
4-6). A poly Ala face that is unlikely to mediate TM-TM dimerization replaced the poly Leu face 
in the helical wheel representation. Both mutant proteins accumulated to abundant levels, but 
again the 40-kDa degradation product was also detected. Surprisingly, strains producing the 
mutant proteins elaborated T-pili and were virulent on plants (Figure 4-6). In general, the levels 
of T-pilus production and substrate transfer approximated levels observed with the 
VirB/FtsNTM-producing strain.  
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These findings would appear to argue against the importance of a Leu zipper motif for 
VirB10 function. However it is possible that the FtsNTM concurrently introduced an unidentified 
dimerizing element that is independent of the putative Leu zipper within the TM sequence. 
This might explain the observed complementation in VirB10 protein function.  
 
  Interestingly, the substitution of the entire N-terminal region of FtsN, including its short 
cytoplasmic domain and TM sequence, for the corresponding domains of VirB10 completely 
abolished protein function (Figure 4-6: panel D). 
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Figure 4-6 FtsN TM domain substitutions 
A.     Helical wheel diagrams for VirB10/FtsNTM derivatives. In red are residues of the 
atypical leucine zipper. 
B.     Sequences for both wild type VirB10 and FtsNTM derivatives.  
C. and D. VirB2 surface and T-pilus shear assays. Total cellular levels of VirB2 and VirB10 are 
included (Bottom panel). Virulence is indicated on a scale of three pluses for wild-type 
virulence to a minus sign for avirulence.   
 
 
Strains: WT, A348; ΔB10, PC1010; FtsN TM substitutions, PC1010 producing VirB10 FtsN 
TMs; FtsN Cyto TM substitution, PC1010 producing VirB10 FtsN Cyto TM. Cyto, cytoplasmic 
domain, TM, transmembrane domain. 
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VirB10 TM domain substitutions: poly Leu-Ala TM domain swaps 
To complement the above approach, I devised a strategy aimed at identifying residues 
in the VirB10 TM domain that are required for function. I created a synthetic TM domain 
comprised of alternating Leu and Ala residues. Previous studies have shown that a poly-
Leu/Ala (pLA) TM sequence forms a stable membrane α-helix, but one that does not interact 
with other TM helices (85). Poly-LA TM substitutions have been used previously to define TM 
helix contributions to protein function (86-88). I constructed and analyzed the phenotypic 
consequences of pLA substitutions of VirB10 TM domain residues 27-50 and 33-50 (Figure 4-
7). For the latter substitution, I also created swaps with and without Trp48. A corresponding 
Ala substitution of Trp48 in the TM domain of native VirB10 was also constructed. The 
rationale for testing the importance of Trp48 was that aromatic residues associated with TM 
domains tend to sit at the membrane – aqueous interface and help stabilize and orient the α-
helix in the membrane (89, 90). I reasoned that Trp48 might influence the functionality of the 
VirB10 TM domain as well as the pLA swap.  
 
The VirB10/pLA27-50 and VirB10/pLA33-50 mutant proteins accumulated at abundant 
levels as a 48-kDa species corresponding in size to native VirB10 (Figure 4-7). A ~40-kDa 
degradation product also accumulated at abundant levels, suggestive of an effect of the pLA 
swaps on protein stability (Figure 4-7). The VirB10/pLA33-50 mutant containing Trp48 
accumulated almost exclusively as the 48-kDa species, further suggesting that Trp48 
stabilizes the pLA mutant proteins possibly as a topogenic signal. Regardless of the presence 
of Trp48, however, strains producing the pLA mutant proteins failed to accumulate detectable 
levels of extracellular VirB2 indicative of a defect in T-pilus production (Figure 4-7). By 
contrast, all three mutant strains were transfer proficient, as shown by the capacity to infect 
plants and transfer the IncQ plasmid to agrobacterial recipients. The mutant strains transferred 
substrates at diminished levels in comparison to strains producing native VirB10; nevertheless, 
the Tra+ phenotype firmly establishes that a nondimerizing pLA α-helix suffices for elaboration 
of a functional translocation channel (Figure 4-7). 
 
The W48A substitution in the context of the VirB10 TM domain did not disrupt protein 
function (Figure 4-7). The mutant protein accumulated predominantly as the 48-kDa species 
and the corresponding mutant strain accumulated abundant levels of extracellular VirB2 pilin 
indicative of T-pilus production. The W48A mutant strain also delivered DNA substrates to 
plants and other agrobacteria (Figure 4-7). Trp48 of native VirB10 thus appears to be 
dispensable for proper insertion of the native TM domain into the membrane.  
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Figure 4-7 poly-LA (poly Leu-Ala) TM substitutions 
A.  Native VirB10 sequence, poly-Leu/Ala (pLA) substitutions, and W48A substitution.  
B.    Extracellular VirB2 as monitored with surface and shear assays. Total cellular levels of 
VirB2 and VirB10 detected by SDS-PAGE and immunostaining with anti-VirB2 and anti-VirB10 
antibodies.  
C. DNA substrate transfer as monitored by virulence on plants and mobilization of an IncQ 
plasmid to agrobacterial recipients. Conjugative IncQ transfer (white bars) is presented as the 
number of transconjugants per donor cell. Virulence (black bars), reported on a scale of 3 
pluses (+) to a negative sign (-) for avirulence.  
 
Strains:  WT, A348; ΔB10, PC1010; PC1010 producing VirB10/pLA TMs or W48A.  
 
 
 
 
 
 
 
 
 
 
 
 
 80 
 
 
 
 
 
 
 81 
Introduction of conserved residues in the VirB10 poly-LA TM domain restores T-pilus 
production  
Next, I sought to identify minimal changes in the pLA TM sequence that would restore 
the capacity of host cells to assemble T-pili. VirB10 subunits of T4SS elaborated by members 
of the Rhizobiaceae contain several invariant residues in their TM domains, including Val39, 
Leu40, Ser43, and Leu44 (Figure 4-1). Leu40 is within the putative LZ1 that might be 
important for T-pilus production (see Figure 4-4). Therefore, I first substituted Leu for Ala40 
(bold) within the S30QKLALALALA40LALALALWLA50 TM sequence. I also substituted Val39, 
Leu40, Ser43, and Leu44 for the Ala or Leu residues at the corresponding positions (above, 
underlined) of the pLA sequence.  
 
The mutant proteins bearing the pLA (L40) and pLA (VL/SL) substitutions accumulated 
at abundant levels and the latter mutant protein also showed appreciably lower amounts of the 
degradation products suggestive of enhanced protein stability (Figure 4-8). Very interestingly, 
strains producing either of the derivatized pLA sequences elaborated T-pilus as deduced from 
the detection of extracellular VirB2 pilin with colony (surface) blot and shear assays. The pLA 
(VL/SL) and pLA (L40) mutant proteins also supported substrate transfer at approximately the 
same levels as the parental pLA mutant as shown with the plant virulence assay (Figure 4-8). 
These findings show that the substitution of only one residue, Leu40, in the pLA TM sequence 
was sufficient for restoration of T-pilus formation to abundant levels.  
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Figure 4-8 Introduction of conserved residues into a poly-LA TM domain restores T-
pilus production 
A. Helical wheel diagrams for VirB10/poly-LA derivatives. 
B.  Schematic showing native VirB10 sequence, the pLA TM domain, and locations of 
residues conserved among VirB10 homologs that were introduced into the pLA sequence  
C.    Extracellular VirB2 as monitored with surface and shear assays. Total cellular levels of 
VirB2 and VirB10 detected by SDS-PAGE and immunostaining with anti-VirB2 and anti-VirB10 
antibodies. Virulence is indicated on a scale of three pluses for wild-type virulence to a minus 
sign for avirulence. 
 
Strains:  WT, A348; ΔB10, PC1010; PC1010 producing VirB10/pLA TM derivatives as listed.  
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VirB10 TM domain weakly self-associates  
The above findings suggest that a putative Leu zipper (LZ1) marked by Leu(Ile) 
residues at positions 33, 40, and 47 of the VirB10 TM domain contributes to assembly of T-pili. 
By contrast, a nondimerizing pLA TM helix suffices for elaboration of a functional translocation 
channel. I envisioned that the putative LZ1 motif might mediate formation of TM-TM helix 
homo- or heterodimers required for T-pilus biogenesis. Homomultimerization is consistent with 
results of early yeast two-hybrid experiments providing evidence for self-association of the N-
terminal third of VirB10 (21). Additionally, as noted above, the N-terminal regions of the 14 
copies of TraF in the pKM101 core complex appear to assemble as a ring as judged by 
CryoEM microscopy (16). Interactions among the N-terminal TM domains might serve to 
stabilize the core ring at the inner membrane. Alternatively – or additionally – the TM domains 
might interact stably or dynamically with other VirB channel subunits to promote assembly or 
dynamic activity of the inner membrane translocase.   
 
I first assayed for VirB10 TM domain self-association by use of TOXCAT, a reporter 
assay developed for quantifying TM self-association within membranes (26). In TOXCAT, a 
chimeric protein is constructed in which a TM sequence of interest is introduced between 
cytoplasmic ToxR, which functions as a transcriptional activator only as a homodimer, and 
periplasmic maltose binding protein (MBP). If two fusion proteins are brought into physical 
juxtaposition due to self-interaction of the TM domains, the ToxR monomers assemble to form 
homodimers that can then activate expression from a ctx promoter. This promoter is 
engineered to direct transcription of a gene for chloramphenicol acetyltransferase (CAT) (26, 
91). Therefore, quantification of CAT activity in lysates of cells expressing these fusion 
proteins serves in direct measure of TM self-association. Proper orientation of the fusion 
protein across the cytoplasmic membrane can be confirmed by assaying for growth of E. coli 
MM39 cells on maltose-containing plates (26, 91).  
 
In setting up the TOXCAT assay, I used the glycophorin A TM domain as a positive 
control; this domain has been shown to strongly self-associate through the GXXXG 
dimerization motif (26). Additionally, the GpA TM domain bearing the G83I mutation served as 
a negative control as this mutation abolishes GXXXG-mediated dimerization (26). Assays 
were carried out in the E. coli malE mutant strain MM39 (see Materials and Methods). This 
strain fails to metabolize maltose in the absence of a ToxR-TM-MBP fusion protein that is 
properly oriented across the cytoplasmic membrane. With TOXCAT, I confirmed that cells 
expressing the gene for ToxR-GpATM-MBP accumulated abundant levels of the fusion protein, 
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grew on maltose containing plates, and possessed high levels of CAT activity suggestive of 
strong dimerization (Figure 4-9 and 4-10). Cells expressing the gene for the GpATM fusion 
protein bearing a G83I mutation also accumulated abundant levels of the fusion protein and 
grew on maltose, but possessed only very low levels of CAT activity (< 5% of that for the 
unmutated TM domain) suggestive of no or very weak dimerization (Figure 4-9 and 4-10). 
 
Given that the VirB10 TM domain possesses a GA4 motif as well as two potential Leu 
zipper motifs, I had anticipated that this TM domain would strongly self-associate. On the 
contrary, although cells accumulated abundant levels of the fusion protein and grew on 
maltose, these cells exhibited only ~20% of the activity of cells producing the GpATM fusion 
protein (Figures 4-9 and 4-10). In several repetitions of these experiments, however, CAT 
activity levels were routinely higher in cells producing the VirB10TM versus the GpATM(G83I) 
fusion proteins (Figure 4-10). The VirB10 TM domain thus appears to self-associate but only 
weakly compared to the GpA TM domain in the context of a TOXCAT fusion protein produced 
in E. coli.  
 
I next sought to determine whether the possible dimerization motifs in the VirB10 TM 
domain promote self-association. I introduced variant TM domains bearing mutations of 
interest (Figure 4-10). As with the fusion protein bearing the native TM domain, proteins with 
mutant TM domains accumulated at abundant levels, and cells grew on maltose suggestive of 
proper orientation of the mutant proteins across the membrane (Figure 4-9 and 4-10). I 
normalized CAT activity of cells producing the VirB10TM fusion protein to 100, and reported 
CAT activities of cells producing the mutant derivatives as a percentage of that value (Figure 
4-10). Recall that A. tumefaciens strains producing VirB10 mutants with i2 mutations at 
positions 35 and 45 in the TM domain were Tra+, PilAtt, whereas a strain with an i2 mutation at 
residue 40 was Tra+, Pil-  (24). In E. coli, production of the 35.i2 or 40.i2 mutant fusion proteins 
yielded CAT activity at levels of 40 – 50% that of the unmutated construct (Figure 4-10). 
However, production of the 45.i2 mutant TM domain yielded CAT activity at WT levels. 
Additionally, Ala substitutions of L33, L40, and I47 also resulted in a reduction by more than 
40% in CAT activity compared to the unmutated VirB10TM fusion protein (Figure 4-10). In A. 
tumefaciens, the corresponding VirB10 mutant protein failed to support T-pilus production. It is 
noteworthy that the 40.i2 mutation shown to abolish T-pilus production in A. tumefaciens would 
disrupt the heptad register of Leu(Ile) residues comprising the putative LZ1 motif. These 
correlative effects of the 40.i2 mutation and LZ1 Ala substitutions on TM dimer formation and 
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T-pilus production are compatible with a model that weak self-association of the VirB10 TM is 
important for T-pilus biogenesis.  
 
I further examined the effects of mutations in the GA4 and LZ2 motifs on TM self-
association. Consistent with their lack of phenotypes in substrate transfer and T-pilus 
production assays in A. tumefaciens, the lle substitutions of G37 and A41 in the GA4 motif did 
not disrupt TM-TM dimerization as monitored by TOXCAT (Figure 4-10). The Ala substitutions 
of V35, L42, and L49 of the putative LZ2 motif also neither affected VirB10 function in A. 
tumefaciens nor TM-TM self-association in E. coli.  
 
Overall, these findings suggest that VirB10 homomultimerization might be selectively 
important for T-pilus formation but not for substrate transfer. To further test this idea I used 
TOXCAT to assay for dimerization of proteins with poly Leu-Ala (pLA) TM sequences. Recall 
that VirB10 with a pLA TM sequence conferred a Tra+, Pil- phenotype in A. tumefaciens, and 
that substitution of Leu40 (L40) and Val39, Leu40, Ser43, and Leu44 (VL/SL) in the pLA 
sequence restored T-pilus production. I hypothesized that the pLA (W48) sequence lacks 
stable TM-TM interactions needed for multimerization and the L40 and VL/SL derivative 
proteins might restore T-pilus formation by concurrently restoring TM-TM self-association. To 
test this hypothesis, I introduced these TM sequences into TOXCAT. These proteins, like the 
pLA(W48) fusion protein, supported growth of MM39 on maltose minimal media confirming a 
correct topology (Figure 4-9). The pLA(W48) and L40 derivatives both supported abundant 
protein accumulation, however, the VL/SL derivative also showed significant degradation 
(Figure 4-11). The pLA (W48) sequence in TOXCAT yielded a very low CAT activity similar to 
the nondimerizing GpA(G83I) negative control (Figure 4-11). This is in agreement with a TM 
sequence lacking a dimerizing interaction. Poly-LA sequences containing the conserved 
residues L40 and VL/SL, yielded TOXCAT fusion proteins that conferred slightly higher CAT 
activity values relative to the nondimering GpA(G83I) and pLA fusion proteins (Figure 4-11). 
However, CAT activity levels exhibited by these pLA derivatives were still low, preventing firm 
conclusions regarding the role of the LZ1 motif for self-association.  
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Figure 4-9 Growth of MM39 cells expressing ToxR-B10TM-MBP proteins on maltose 
minimal media  
MM39 (malE) cells expressing ToxR-B10TM-MBP were streaked on 0.4% maltose M9 minimal 
media plates and tested for growth at 37°C for 2 days. Cell viability indicates a topology in 
which the maltose-binding domain is periplasmic.   
 
Strains: MM39, empty vector; pMal-p2 and –c2, + and – control; GpA, strong dimerizing 
control; GpA(G83I), nondimerizing control; B10 and listed mutations, native and mutagenized 
TM sequences introduced into the TOXCAT vector, pccKan, expressed in MM39. 
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Figure 4-10 Quantification of CAT activity from cell lysates expressing ToxR-B10TM-MBP 
fusion proteins  
A.   Quantification of CAT activity for cells synthesizing fusion proteins with the TM 
sequences of GpA, the nondimerizing GpA(G83I) mutant, and native VirB10. Bottom: western 
blot analysis of whole cell extracts.  
B.  Quantification of CAT activity for cells synthesizing fusion proteins with native and 
mutant VirB10 TM sequences. CAT activities are normalized to that of cells synthesizing the 
TOXCAT reporter with the native VirB10 TM domain.  
 
Strains: GpA, strong dimerizing control; GpA(G83I), nondimerizing control; E. coli MM39(malE) 
producing the TOXCAT reporter with native and mutant VirB10 TM sequences as listed. 
 
 
 
 
 
 
 
 
 
 90 
 
  
 
 91 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-11 TOXCAT with poly-LA sequences 
Quantification of CAT activity for cells synthesizing fusion proteins with the TM sequences of 
GpA, the nondimerizing GpA(G83I) mutant, and various pLA sequences. Bottom: western blot 
analysis of whole cell extracts. 
 
Strains: GpA, strong dimerizing control; GpA(G83I), nondimerizing control; E.coli  MM39 
(malE) producing the TOXCAT reporter with various pLA sequences as listed. 
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VirB10 TM domain mutations do not disrupt outer membrane channel gating 
The above findings suggest that the VirB10 TM domain self-interacts although weakly 
compared with the GpA TM domain. Mutations in the putative LZ1 motif diminish self-
association, and this might account for the associated Pil- phenotype in A. tumefaciens.  
However, another possible explanation for the block in T-pilus production is that the LZ1 motif 
mediates formation of VirB10 heterodimers with another channel subunit in A. tumefaciens. 
Candidate partner proteins include the bitopic or polytopic VirB subunits VirB2, VirB3, VirB4, 
VirB6, or VirB8, or the substrate receptor VirD4. Deciphering the nature of the possible 
heteromeric TM-TM helix interactions involving VirB10 is beyond the scope of this study. 
However, earlier studies in the Christie laboratory provided evidence that VirB10 regulates 
formation or gating of the distal portion of the translocation channel near or across the outer 
membrane in response to sensing of ATP energy use by the cytoplasmic membrane ATPases 
VirD4 and VirB11 (20). Consistent with this earlier work, recently our collaborator, Dr. L. Banta 
at Williams College, isolated a VirB10 mutation, G272R, that confers the nonspecific release of 
the VirE2 secretion substrate to the extracellular milieu. This mutation appears to lock VirB10 
in an energy-activated conformation so that substrates are delivered across the outer 
membrane even in the absence of target cell contact. Interestingly, the G272R mutation does 
not affect substrate transfer to target cells, but it does block T-pilus biogenesis (L. Banta, 
personal communication).   
 
I hypothesized that the TM domain mutations conferring the Pil-, Tra+ phenotype might 
phenocopy the G272R mutation in causing release of secretion substrates to the extracellular 
milieu. Mechanistically, this could occur if the TM domain mutations disrupt interactions with 
one or more of the energizing ATPases. To test this possibility, I assayed for surface display of 
a FLAG-epitope tagged VirE2 substrate, which was shown by the Banta laboratory to be 
released in the G272R mutant strain. By use of a colony immunoblot assay, Jennifer E. Kerr 
and I confirmed that A. tumefaciens producing the G272R mutant protein releases FLAG-
VirE2 to the cell surface, whereas strains producing native VirB10 do not release this secretion 
substrate (Figure 4-12). Interestingly, strains producing the VirB10 TM mutant proteins 
conferring the Tra+, Pil- phenotype (40.i2, triple Ala-substituted LZ1, pLA) showed no release 
of FLAG-VirE2 (Figure 4-12). Similarly, strains with other TM mutations  (FtsN swap, triple Ala-
substituted LZ2) also did not release the FLAG-VirE2 substrate at detectable levels. These 
findings suggest that the VirB10 TM domain mutations do not act indirectly on outer 
membrane channel activity or integrity, but instead block T-pilus production at an earlier step 
in the biogenesis pathway.   
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Figure 4-12 Outer membrane gating defect assay (release of FLAG-VirE2 substrate) 
Surface colony assay monitoring the release of FLAG-VirE2. Equivalent vir-induced cells 
where spotted on ABIM inducing media plates, and allowed to grow for 3 days. Surface 
proteins from induced colonies were transferred to nitrocellulose membranes and incubated 
with an anti-VirE2 antibody (Top panel). Induced cells were also tested for cellular levels of 
FLAG-VirE2 and VirB10 by western blot analysis (Bottom panel). 
 
Strains: WT, A348; ΔB10, PC1010; VirB10 mutations, PC1010 carrying VirB10 with listed 
mutations.  
 
The G272R mutation was isolated and characterized by L. Banta at Williams College.   
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Discussion  
In this study, I explored the contributions of putative dimerization motifs in the VirB10 
transmembrane (TM) sequence for TM self-association, and T4SS channel activity and T-pilus 
biogenesis. One of the most interesting findings from my work is that substitutions of the TM 
domain for heterologous transmembrane sequences, including the FtsN TM domain and a 
synthetic pLA sequence, do not abolish substrate transfer. Although it is formally possible that 
the FtsN TM domain could mediate assembly of dimers required for VirB10 function through 
interactions motifs that are not defined at this time, previous findings established that the pLA 
TM sequence does not dimerize (86, 87, 92). On the basis of these findings, I conclude that 
VirB10 requires only a TM membrane anchor, not TM-mediated homo- or heteromeric 
contacts, for assembly of a functional translocation channel. 
 
The lack of sequence specificity of the VirB10 TM domain for substrate transfer is of 
interest in view of data from the Christie laboratory and other groups that VirB10-like proteins 
interact with VirD4-like substrate receptors (48, 52, 53). These substrate receptors typically 
have two N-terminal TM domains with a short, intervening loop located in the periplasm. A 
crystal structure of one substrate receptor, TrwB of the plasmid R388 conjugation system, 
presented as a homohexameric sphere with a central channel (93, 94). The N-terminal TM 
domain was modeled as a stem-like projection extending from the sphere across the inner 
membrane (95). Two-hybrid studies localized the regions involved in the interaction between 
homologs of VirB10 and VirD4 to their N-terminal halves, leading to a proposal that these 
proteins might interact via their TM domains (52, 53). Although this has not been tested 
directly, a recent mutational analysis further identified mutations in the TM domains of VirB10-
like and VirD4-like subunits that resulted in stronger interactions in a two-hybrid screen (96). 
These findings led to a proposal that substrate receptors interact with T4SS core complexes 
via TM-TM domain interactions (96). However, my findings that heterologous TM domains, 
including a monomeric pLA TM sequence, functionally substitute for the VirB10 TM domain for 
substrate transfer argue strongly that the TM domain does not by itself mediate the VirB10 – 
VirD4 interaction. It is noteworthy that I found that the substitution of the entire N-terminal 
region of FtsN, including its short cytoplasmic domain and the TM sequence, for the 
corresponding domains of VirB10 completely abolished protein function (Figure 4-6). 
Moreover, VirB10 deleted of both of these N-terminal domains does not form an 
immunoprecipitable complex with VirD4 (24). Together, these data suggest that the N-terminal 
cytoplasmic domain of VirB10 might mediate VirD4 partner binding and that VirB10 TM 
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domain acts only indirectly on VirD4 complex formation. Future studies will examine this 
possibility. 
 
VirD4 is not required for T-pilus biogenesis (97). Therefore, it is not surprising that 2-
residue insertion mutations in the VirB10 TM domain that selectively blocked T-pilus 
biogenesis did not disrupt formation of a precipitable VirB10-VirD4 complex (24). While the 
role of the VirB10 TM domain in T-pilus biogenesis is not completely defined, my findings did 
identify contributions of putative dimerization motifs. A GA4 motif, like the structurally similar 
GG4 motif, is overrepresented in transmembrane helices and mediates helix-helix interactions 
in membrane proteins (75, 98). The noted conservation in VirB10 of the extended version of 
the GG4 motif (LIxxGVxxGVxxT) prompted a test of the functional importance of this motif; 
however, substitutions of Gly37 and Ala41 with a bulky Ile residue were phenotypically silent. 
For GpA, the extended GG4 motif forms a homodimeric interface and, in agreement with 
previous findings (26), I determined that a G83I mutation completely abolishes GpA-mediated 
dimerization as shown with the TOXCAT assay (Figure 4-10). Interestingly, even though 
VirB10 carries an extended motif (LIxxGVxxALxxS) similar to that of GpA, the VirB10 TM 
domain only weakly dimerizes and the Ile substitution mutations do not further diminish 
homodimer formation as quantitated by TOXCAT (Figure 4-10). My studies do not exclude the 
possibility that the GA4 motif mediates formation or stabilization of TM-TM heterodimers with 
other VirB channel subunits, but even if this were the case, results of the mutational studies 
establish that any GA4-mediated dimerization is completely dispensable for VirB10 function.   
 
The extended GG4 or GA4 motifs conform to a repeat designated as [abcd]n where the 
a and b residues form a right-handed helix-helix interface (75, 77, 99). By contrast, the second 
type of dimerization motif identified in the VirB10 TM domain, the Leu zipper, forms dimeric 
contacts via a [abcdefg]n heptad repeat in which residues at the a and d positions form a left-
handed helix-helix interface (100). Leu zipper-mediated dimerization is most commonly 
reported for soluble binding partners, but a number of eukaryotic and virus membrane proteins 
have been shown to form partner interactions via Leu zipper motifs in TM sequences (70-73). 
In bacteria, Leu-zipper mediated dimerization of TM helices has not been reported, although a 
Leu zipper domain of the GCN4 transcription factor was found to functionally substitute for the 
TM domain of the A. tumefaciens VirA sensor kinase (101). Leu-to-Ala substitutions disrupt 
Leu zipper-mediated interactions, and here I showed that Ala substitutions of the putative LZ1 
motif (L33, L40, I47) block T-pilus formation. In contrast, Ala substitutions of the putative LZ2 
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motif (V35, L42, L49) were phenotypically silent, indicating that this Leu interface is not 
required for VirB10 function.  
 
I extended my analyses of the VirB10 TM domain and the LZ1 motif by substituting 
heterologous TM domains for the native sequence. Introduction of the FtsN TM sequence 
resulted in a TM sequence that retained the LZ1 motif but little other sequence identity with the 
VirB10 TM sequence. The corresponding VirB10/FtsNTM mutant protein displayed WT 
function; however, so also did the same chimeric protein bearing Ala substitutions of the LZ1 
residues. This could raise questions about the importance of the VirB10 LZ1 motif, but an 
alternative possibility is that the chimeric VirB10/FtsN TM sequence possesses another 
dimerization motif that functionally substitutes for the LZ1 motif. While further studies are 
needed to explore this possibility, I also tested whether substitution of a TM sequence devoid 
of a dimerization motif would impact VirB10 function. The poly-LA sequence is monomeric and 
all three swaps that I constructed (27-50, 33-50, 33-50 with W48 retained) phenocopied the 
Leu-to-Ala substitutions of the LZ1 motif in blocking T-pilus production and supporting 
substrate transfer. I also confirmed that the pLA motif does not mediate assembly of TM 
homodimers in the TOXCAT assay consistent with previous reports (86, 87, 92). 
   
Starting with the monomeric pLA sequence, I next attempted to restore the capacity of 
cells to assemble T-pili by reintroducing residues that are conserved among VirB10 homologs.  
Intriguingly, substitution of a single Leu for Ala at position 40 in the TM sequence resulted in 
accumulation of appreciably higher levels of T-pilus, as did substitution of conserved residues 
Val39, Leu40, Ser43, and Leu44. The Leu40 substitution restores the LZ1 motif (L33, L40, 
I47), which could account for the gain-of-function phenotype with respect to T-pilus assembly. 
However, the pLA TM sequence and the two derivatives bearing substitutions of conserved 
residues showed only weak dimerization as monitored by TOXCAT. These findings suggest 
that the putative LZ1 motif does not mediate formation of strong TM-TM homodimers, at least 
in E. coli.    
 
I can envision three explanations for why substitutions of conserved residues into the 
pLA sequence restore T-pilus production in A. tumefaciens but not homodimer formation as 
monitored by TOXCAT in E. coli. First, as shown for some Leu zipper motifs of soluble 
proteins (102, 103), the VirB10 LZ1 motif might instead mediate a heteromeric interaction 
required for T-pilus biogenesis. As noted above, there are several VirB channel subunits, 
including VirB2, VirB3, VirB4, VirB5, VirB6, or VirB8, with which VirB10 might interact for T-
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pilus production. These interactions would not have been identified with our TOXCAT assay 
although future studies with a variant of the TOXCAT assay (104) could reveal such 
heteromeric TM helix-helix interactions. Alternatively, it is conceivable that LZ1 motif weakly or 
dynamically self-associates in A. tumefaciens and that this type of TM-TM self-association is 
essential for VirB10 to function in T-pilus assembly. A weak, or for that matter, strong TM 
helix-helix interaction might form in the context of the assembled VirB7/VirB9/VirB10 core 
complex but not the TOXCAT constructs in E. coli. Finally, it is possible that the VirB10 TM 
domain contributes indirectly to establishment of homo- or heterotypic interactions through 
structural effects on the adjacent cytoplasmic or Pro-rich periplasmic domains. The TM 
mutations shown to affect T-pilus production could exert their effects by imposing a structural 
change or constraint on one of both of these extramembranous domains.  
 
Besides considering my experimental findings, it is important to incorporate the 
available structural information in development of models depicting how the VirB10 TM domain 
might contribute to T-pilus biogenesis. On the basis of the pKM101 core complex visualized by 
CryoEM and X-ray crystallography, it is proposed that VirB10-like subunits, together with VirB7 
and VirB9-like subunits form a ring-shaped complex that spans both membranes and the 
intervening periplasmic space (15, 16). This core complex serves as a scaffold upon which the 
translocation channel is assembled, most likely within the core’s chamber. We further 
postulate that the core complex serves as a scaffold for T-pilus assembly. T-pili might 
assemble from i) an inner membrane platform within the core’s chamber or ii) an outer 
membrane platform formed by the core complex. Although it is not possible at this time to 
discriminate between the inner versus outer membrane assembly models, we envision that for 
both models the VirB2 pilin subunit must gain access to the core chamber for T-pilus 
polymerization. If so, the pool of pilin monomers that accumulates within the inner membrane 
for use in building T-pili must translocate from their site of membrane insertion into the core 
chamber at an early stage of the assembly pathway. Accordingly, during translocation through 
the membrane, pilin monomers would encounter VirB10 TM domains configured as a 14-
membered ring encircling the chamber. The nature of VirB10 TM-TM helix homo- or 
heterotypic interactions could thus be critical for this step of T-pilin translocation.   
 
If I assume that the 14 VirB10 TM domains form only homotypic interactions, there are 
two possible TM helical arrangements (Figure 4-13). Each helix might interact with both 
adjacent helices forming a 14-membered ring. In this scenario, an LZ1 motif (L33, L40, I47) of 
one subunit might interact with the LZ2 motif (V35, L42, L49) of an adjacent subunit, making a 
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ringed complex of interacting α-helices (Figure 4-13: panel A). For the pilin to translocate 
through such a ringed complex, transient breaks in the ringed complex would need to occur. 
However, arguing against such a structural arrangement, I showed that the putative LZ2 motif 
is completely dispensable whereas putative LZ1 motif is required for T-pilus production. Thus, 
an alternative structural arrangement is that an LZ1 motif of one VirB10 monomer interacts 
with an LZ1 motif of an adjacent monomer. The resulting structure is a 14-membered ring 
comprised of 7 TM-TM dimers (Figure 4-13: panel B). This model is in agreement with my data 
demonstrating the functional importance of the LZ1 motif and also with results of the TOXCAT 
assays showing that LZ1 mutations abrogate VirB10 self-association. This model would also 
accommodate the proposed requirement for pilin subunits to translocate across the 14-
membered ring of TM helices as adjacent VirB10 dimers need not be physically associated.   
 
As noted above, however, at this point we cannot rule out the possibility that the VirB10 
TM domain forms heterotypic interactions with other channel subunits. It seems unlikely that 
the VirB10 TM domain would interact stably with the VirB2 pilin although a transient weak-
affinity interaction might be important for guiding the pilin into the core chamber. Additionally J. 
Kerr in our lab recently supplied evidence that the VirB4 ATPase mediates dislocation of VirB2 
pilin from the inner membrane (105). S. Jakubowski in our lab also has supplied evidence that 
VirB10 interacts with the VirB4 ATPase (unpublished data). In view of these findings, the 
VirB10 TM domain might interact with VirB4 as a means of spatially localizing pilin dislocase 
activity at the core complex. VirB3 has been shown to interact with VirB4 and thus represents 
yet another candidate interacting subunit with the VirB10 TM domain (106, 107). Other 
candidate subunits VirB6 and VirB8, two proteins that likely comprise part of the translocase at 
the inner membrane. A model depicting VirB10 TM domain heterotypic interactions is shown in 
Figure 4-13 panel C. Finally, it is conceivable that VirB10 participates in a mix of homotypic 
and heterotypic interactions - stably or dynamically - within the lipid environment of the inner 
membrane (Figure 4-13: panel D).  
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Figure 4-13 Model depicting VirB10 helical TM packing  
A. TM ring model were individual and adjacent TM domains interact by contacts between 
different Leu zipper motifs (LZ1; red and LZ2; blue).  
B. Contacts via LZ1 creates TM dimers. 
C. Heterotypic interactions occur via contacts between LZ1 and another VirB protein.  
D. Model depicting a mix of homo- and heterotypic interactions. 
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Chapter 5. Summary and Perspectives  
Summary 
Type IV secretion systems are large multiprotein complexes consisting of a dynamic 
network of 11 VirB proteins and the coupling protein, VirD4 (4). These systems assemble a 
transenvelope secretion channel that functions to transport macromolecules across cell 
membranes and many also assemble surface filaments or T-pili. This thesis is centered on 
advancing our understanding of type IV substrate secretion and T-pilus biogenesis through a 
mutational analysis of VirB10. 
 
In chapter 3, I identified phenotypes associated with Ala-Cys insertions and Cys 
substitution mutations along the length of VirB10. In general, Ala-Cys insertions in the N-
terminal cytoplasmic and TM domains had marginal effects on protein function. However, a 
few insertions nearly or completely blocked T-pilus biogenesis (Ala-Cys inserted at 35, 40, and 
45) (24). Further analysis of these N-terminal insertion mutations along with C-terminal Cys 
substitutions confirmed a bitopic topology. 
 
Phenotypic studies of proteins with Cys substitutions gave various phenotypes when 
assayed for effects on protein function, and ability to form high molecular weight species in 
nonreducing gels. Interestingly most of the Cys derivative proteins formed large molecular 
weight species consistent with a homodimer (~105-kDa). Thus VirB10 forms an extended 
protein interface with itself, which is in agreement with recent structural information of the 
VirB10 homolog (TraF) in the pKM101 core complex (15, 16). 
 
In view of the X-ray crystal structure of the outer membrane layer composed of TraF, 
TraN, and TraO, it is possible but unproven that the AP domain of TraF/VirB10 functions as an 
outer membrane pore (15). Several Cys substitutions were introduced into the AP domain of 
VirB10. These mutant proteins were first tested for effects on protein function and then used in 
surface accessibility studies with an outer membrane impermeable thiol reactive compound, 
MPEG. In these studies, I was not able to detect reactivity with MPEG and thus unable to 
validate surface accessible sites along the AP domain of VirB10. One possibility could be that 
the AP domain is only transiently surface accessible or other surface proteins block its 
accessibility. By contrast, MPB labeling in different genetic backgrounds of Cys mutant 
proteins provided some initial evidence that the AP domain exists in different structural states 
in the absence versus presence of other VirB proteins. Therefore, the possibility that the AP 
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domain of VirB10 functions as the outer membrane pore is still a subject of debate and further 
study. 
 
In chapter 4, I characterized the contributions of the TM domain to VirB10 function, 
specifically T-pilus formation. I described the identification of various TM dimerizing motifs and 
subsequently introduced mutations to characterize the contributions of these motifs to protein 
function. Results of these mutational studies showed that a GA4 motif and LZ2 (V35, L42, L49) 
Leu zipper motif do not contribute to VirB10 function. In contrast, the putative LZ1 (L33, L40, 
I47) Leu zipper does seem to contribute to T-pilus formation. To further examine this proposal, 
I created and phenotypically characterized several pLA and FtsN TM domain substitutions. 
Proteins with pLA TM substitutions were very reduced for T-pilus formation and substrate 
transfer. Interestingly the introduction of conserved native residues into the pLA TM sequence 
restored T-pilus production. By contrast proteins with FtsN TM substitutions complemented 
protein function even in FtsN TM sequences containing Ala substitutions in the putative LZ1 
motif.  
 
The ability of various TM sequences to self-associate was measured using the 
TOXCAT assay. The TM sequence of native VirB10 was found to have a weak dimerizing 
affinity when compared to GpA. Most mutagenized TM sequences had similar self-association 
affinities to native B10, however, there were two exceptions: i) the TM carrying the 40AC 
insertion and ii) the TM carrying the triple Ala substitutions in LZ1 (L33, L40, I47). Both of 
these mutations abolished T-pilus production in A. tumefaciens. Therefore, mutations that 
block T-pilus formation also confer slight reductions in TM-TM self-association.  
 
Mutations in the TM domain blocked or reduced T-pilus production whereas partial 
deletion of the AP caused release of pilin monomers into the mileu (24), indicating a defect in 
pilin polymerization. These results are supportive of a hypothesis that the TM and AP domain 
contribute to T-pilus biogenesis at distinct steps in the biosynthetic pathway. The TM domain 
might contribute in some way to the recruitment of pilin monomers to the core channel, 
whereas the AP might function as a platform for pilin polymerization or gate T-pilus extension.  
 
I hypothesize that the VirB10 core complex functions as a structural scaffold for the 
assembly of the T-pilus (Figure 5-1). This working model describes VirB2 pilin subunits as 
accumulating in the inner membrane prior to polymerization. Next, VirB2 pilin monomers enter 
the core complex via lateral movement in the inner membrane through an open VirB10 TM 
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gate. One working model is that adjacent VirB10 TM’s dimerize via their LZ1 (L33, L40, I47) 
motif. This homotypic contact between TM helices creates a space between adjacent TM 
dimers (Figure 5-1: I). I hypothesize that this space is used by VirB2 to enter the lumen of the 
core complex to then form a nascent T-pilus filament. This filament subsequently extends and 
protrudes out of the core channel and likely makes subunit contacts with the AP domain of 
VirB10 (Figure 5-1). According to this model, the AP might serve as a gate that allows 
passage of the T-pilus across the outer membrane. However, an alternative model is pilin 
subunits enter the core chamber and are transferred to the AP domain at the cell surface were 
the AP functions as an outer membrane platform upon which the T-pilus assembles.  
 
At this time, we cannot exclude the possibility of heterotypic interactions involved in the 
recruitment and delivery of VirB2 pilin monomers into the interior of the core channel. The 
Christie laboratory has recently provided evidence for VirB4 dislocation of VirB2 pilin from the 
inner membrane (105). This process was described as necessary in the initial steps of T-pilus 
biogenesis. These findings coupled with studies describing the contributions of VirB10 led to a 
model were VirB4 might coordinate with VirB10 via TM helical interactions to dislocate and 
transfer VirB2 pilin to the core channel (Figure 5-1: II). Moreover, VirB2 pilin once in the core 
channel or during the dislocation process likely undergoes structural changes necessary for T-
pilus polymerization.  
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Figure 5-1 Models depicting contributions of VirB10 TM helices to entry of VirB2 pilin 
subunits into the core complex 
I. VirB10 TM helical self-association contributes to entry of VirB2 pilin monomers via 
an open inner membrane TM gate. An inner membrane pool of VirB2 pilin 
accumulates and moves laterally to enter the lumen of the core complex via spaces 
created by VirB10 dimers. VirB2 pilin within the core complex polymerize and 
assemble a T-pilus filament that extends and exit the outer membrane pore 
composed of the AP domain of VirB10.  
II. An alternative model describing VirB2 pilin entry and transfer into the core complex 
is through dislocation by the ATPase VirB4. In this model VirB4 coordinates with 
VirB10 possibility through TM helical contacts to transfer VirB2 pilin into the interior 
of the core channel for subsequent pilin polymerization reactions.  
 
VirB7, VirB9, and VirB10 form a core complex as shown through cryoelectron microscopy from 
homologues in the pKM101 conjugation system (16). This core complex is composed of 14 
copies of each of TraF, TraN, and TraO in a 1:1:1 stoichiometric ratio (16). Here a cartoon 
representation of this structure is provided.  
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Future experiments  
Future experiments will be centered on testing contributions of the TM domain in 
mediating heterotypic contacts with other VirB proteins. Two unanswered questions will be 
explored: (i) does VirB10 interact with VirB2 or VirB4 via TM helical or AP contacts, (ii) is the 
core complex a structural scaffold for the T-pilus?  
Do the VirB10 TM or AP domains mediate subunit contacts with VirB2 pilin? 
I rationalize that if VirB2 enters and assembles within the core complex a number of 
possible subunit contacts will occur. First TM-TM contacts will occur between VirB10 and 
VirB2 pilin as a result of lateral movement through the inner membrane. Second, the 
assembled T-pilus will make contact with the outer membrane pore composed of the AP 
domain of VirB10 as the T-pilus elongates and extends to the cell surface. Thus VirB10 makes 
two possible subunit contacts with VirB2 in the proposed T-pilus biogenesis process: i) in the 
inner membrane by TM helical interactions for pilin entry into the core, and ii) in the outer 
membrane pore for T-pilus extension to the cell surface.  
Do VirB10 and VirB4 interact?  
An alternative model describing VirB2 entry and delivery into the interior of the core 
complex is through dislocation by the ATPase VirB4. According to this model, VirB4 dislocates 
VirB2 from the inner membrane and in coordination with VirB10, VirB2 is shunted into the core 
complex for subsequent polymerization reactions. This model suggests a stable interaction 
between VirB4 and VirB10 for transfer of VirB2 into the core channel.  
 
To test for subunit contacts between VirB10, VirB2, and VirB4, I propose co-
immunoprecipitation (Co-IP) and cross-linking studies as well as a two-hybrid system designed 
for testing heterotypic interactions between membrane proteins (104). 
 
 The goal of these Co-IP studies is to isolate complexes of VirB10, VirB2, and VirB4 
with native VirB10 versus VirB10 containing TM or AP domain mutations. Chemical cross-
linking will be applied to stabilize transient or weak interactions.  
 
 To define areas of subunit contacts I propose cross-linking studies with Cys derivative 
proteins of VirB10 and VirB2. Recall from chapter 3, several Cys residues were introduced into 
the AP and TM domains of VirB10. These Cys derivative proteins will be co-expressed in 
strains producing Cys-substituted VirB2 mutants and tested for presence of molecular weight 
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crosslinks between VirB10 and VirB2. Cross-linking will be done in the presence of the oxidant 
copper-phenanthroline.  
 
 To determine heterotypic association between TM segments of VirB10 with VirB2 and 
VirB4, GALLEX, a two-hybrid system for membrane proteins could be used (104). This system 
like TOXCAT, is a reporter system were fusion proteins are produced with altered TM 
sequences in E. coli. Association of fusion proteins is driven by heterotypic interaction 
between TM helices and causes the repression of a reporter gene (104). This system will be 
used to test for TM helical interactions between the TM segments for VirB10 with VirB2, and 
VirB10 with VirB4.  
Complex isolation through the use of an N-terminal profinity-VirB10 
To test the hypothesis that the core channel serves as a scaffold or chaperone for the 
T-pilus, isolation conditions will be developed to detect and analyze assemblies of the core 
channel complex. I constructed an N-terminal profinity tagged VirB10 (see Materials and 
Methods). Protein purification using the profinity system first includes attaching the 8kDa tag to 
VirB10. Cell lysate containing the tagged protein is passed through a column packed with a 
S189 mutant subtilisin protease resin. The profinity tag contains a subtilisin 
recognition/cleavage sequence (EEDKLFKAL); therefore the tagged protein is bound with high 
affinity to the resin. The resin is washed to remove unbound proteins. Elution is achieved by 
triggering the S189 subtilisin to cleave the recognition/cleavage sequence via incubation in 
buffers of high ionic concentration. Profinity-VirB10 does accumulate however at reduced 
levels and supports substrate transfer and T-pilus production (Figure 5-2). Thus the N-terminal 
tag does not abolish protein function, and is suitable for protein purification and structural 
studies.  
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Figure 5-2 Effects of profinity-VirB10 fusion on protein function 
From top: T-pilus production by VirB2 surface assay. Total cellular levels of VirB2 and VirB10 
detected by SDS-PAGE and immunostaining with anti-VirB2 or anti-VirB10 antibodies. 
Virulence is reported on a scale of three pluses for wild-type virulence to a minus sign for 
avirulent. 
 
Strains: WT, A348; ΔB10, PC1010; profinity-VirB10, PC1010 producing profinity-VirB10.  
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